Skip to main content
eLife logoLink to eLife
. 2020 Nov 25;9:e59489. doi: 10.7554/eLife.59489

Wnt3 distribution in the zebrafish brain is determined by expression, diffusion and multiple molecular interactions

Sapthaswaran Veerapathiran 1,2, Cathleen Teh 1,2, Shiwen Zhu 1,2, Indira Kartigayen 1,2, Vladimir Korzh 3, Paul T Matsudaira 1,2, Thorsten Wohland 1,2,4,
Editors: Tanya T Whitfield5, Marianne E Bronner6
PMCID: PMC7725503  PMID: 33236989

Abstract

Wnt3 proteins are lipidated and glycosylated signaling molecules that play an important role in zebrafish neural patterning and brain development. However, the transport mechanism of lipid-modified Wnts through the hydrophilic extracellular environment for long-range action remains unresolved. Here we determine how Wnt3 accomplishes long-range distribution in the zebrafish brain. First, we characterize the Wnt3-producing source and Wnt3-receiving target regions. Subsequently, we analyze Wnt3 mobility at different length scales by fluorescence correlation spectroscopy and fluorescence recovery after photobleaching. We demonstrate that Wnt3 spreads extracellularly and interacts with heparan sulfate proteoglycans (HSPG). We then determine the binding affinity of Wnt3 to its receptor, Frizzled1 (Fzd1), using fluorescence cross-correlation spectroscopy and show that the co-receptor, low-density lipoprotein receptor-related protein 5 (Lrp5), is required for Wnt3-Fzd1 interaction. Our results are consistent with the extracellular distribution of Wnt3 by a diffusive mechanism that is modified by tissue morphology, interactions with HSPG, and Lrp5-mediated receptor binding, to regulate zebrafish brain development.

Research organism: Zebrafish

Introduction

Wnt proteins represent a family of secreted signaling glycoproteins having multiple functions in embryonic development such as specification of the vertebrate axis, embryonic induction, maintenance of cell potency, cell fate determination, cell migration, cell division, and apoptosis, to name a few (Clevers and Nusse, 2012; Hikasa and Sokol, 2013; Logan and Nusse, 2004; Moon et al., 2002). So far, 13 wnt gene subfamilies have been identified, although the number of wnt genes differs between species (Schubert and Holland, 2013). Wnts are generally 350–400 amino acids in length (molecular weight of ∼40 kDa), with highly conserved cysteine residues. Wnts are hydrophobic and water insoluble due to their post-translational lipidation in the endoplasmic reticulum (ER) (Mikels and Nusse, 2006). Porcupine (Porc), an O-acyltransferase localized on the membrane of the ER, catalyzes the acylation of Wnts and provides Wnts hydrophobic characteristics (Herr and Basler, 2012). The acylation facilitates the interaction of Wnts with Wntless, a transmembrane protein that shuttles Wnts to the plasma membrane (Galli et al., 2007). From the plasma membrane, they are secreted and transported to Wnt-receiving cells. Hence, the acylation of Wnts is a critical step for their trafficking, secretion, and activity (Coudreuse and Korswagen, 2007).

However, the addition of lipid moieties makes the long-range diffusion of Wnts in the aqueous extracellular matrix problematic. Several transport mechanisms were proposed to explain how Wnts navigate the aqueous environment to achieve long-range action (Routledge and Scholpp, 2019). Facilitated shuttling of Wnts by chaperone proteins is a commonly reported mode of distribution. Here Wnt-binding proteins such as secreted Frizzled-related proteins (sFRPs) (Esteve et al., 2011; Mii and Taira, 2009), secreted Wg-interacting Molecule (Swim) (Mulligan et al., 2012), or afamin (Mihara et al., 2016) shield the hydrophobic regions of Wnts and provide stability in the aqueous environment. Similarly, hydrophobic Wnt ligands could be packaged inside exosomes and lipoprotein particles, which enable their extracellular movement (Greco et al., 2001; Neumann et al., 2009; Panáková et al., 2005). Additionally, heparan sulfate proteoglycans (HSPG) present in the extracellular matrix serve as binding sites for several signaling molecules, including Wnts (Kirkpatrick and Selleck, 2007). HSPG maintains the solubility of Wnt ligands and prevents their aggregation in the aqueous extracellular matrix, thereby enhancing their signaling range (Fuerer et al., 2010; Mii et al., 2017). Further evidence suggests that HSPG in coordination with Wnts are pivotal in regulating gastrulation, neurulation, and axis formation during embryonic development (Ohkawara et al., 2003; Saied-Santiago et al., 2017; Tao et al., 2005; Topczewski et al., 2001). On the other hand, it was also recently noticed that certain Wnts could be deacylated by Notum, a secreted deacylase, and maintain reduced signaling activity (Speer et al., 2019). Besides the extracellular transport mechanism, certain Wnt proteins may also reach their target tissues through filopodial extensions called cytonemes, as seen for Wnt2b in Xenopus (Holzer et al., 2012), Wg in Drosophila (Huang and Kornberg, 2015), and Wnt8a in zebrafish embryos (Mattes et al., 2018; Stanganello et al., 2015).

Finally, when Wnts reach their target tissues, they bind to their target receptors and elicit a signaling cascade. To date, Wnts are known to interact with more than 15 receptor and co-receptor protein families (Niehrs, 2012), of which the Frizzled (Fzd) receptor super-family is the most commonly investigated. Fzd proteins are categorized under the Class-F super-family of G-protein coupled receptors. The super-family comprises 10 Fzd receptors (Fzd1-Fzd10) and Smoothened (SMO) (Schulte and Wright, 2018), all with a seven-pass transmembrane domain and a highly conserved cysteine-rich domain (CRD) (Hsieh et al., 1999; Wu and Nusse, 2002). Structural studies revealed that the low-density lipoprotein receptor-related protein (Lrp-5/6) acts as a co-receptor and is involved with the Wnt-Fzd complex (Chu et al., 2013; Hirai et al., 2019; Janda et al., 2012). The Wnt-Fzd-Lrp complex inhibits the negative regulator destruction complex and stabilizes the Wnt signaling transducer β-catenin, which allows the transcription of genes regulating embryonic development and patterning (Bilic et al., 2007).

Wnt3 proteins, a subset of the Wnt family, are instrumental in the development of the nervous system, vascular system, limb formation, and vertebrate axis formation (Anne et al., 2013; Bulfone et al., 1993; Clements et al., 2009; Garriock et al., 2007; Liu et al., 1999). In zebrafish, Wnt3 directs neural stem cell proliferation and differentiation, making it indispensable for brain development (Clements et al., 2009). Our group showed that in zebrafish embryos, Wnt3 associates with domains on the membrane (Azbazdar et al., 2019; Ng et al., 2016; Sezgin et al., 2017). Blocking the activity of Porc and thus reducing Wnt acylation resulted in reduced domain confinement and defective brain development in zebrafish embryos (Ng et al., 2016; Teh et al., 2015). The understanding of the Wnt3 action mechanism in zebrafish brain development, therefore, requires identifying its source regions, determining its mode of transport, demarcating receiving target tissues, and measuring Wnt3-receptor interactions.

In this study, we first mapped the source and target regions of Wnt3 in the zebrafish brain by comparing the expression of a transgenic line expressing functional Wnt3EGFP, with a reporter line expressing an inner plasma membrane targeting sequence tagged with mApple (PMTmApple). The expression in both lines is regulated by a 4 kb wnt3 promoter that contains most of the regulatory elements and reports the spatiotemporal expression of wnt3 (Teh et al., 2015). Wnt3EGFP spreads from where it is produced, while PMTmApple remains attached to the inner membrane leaflet of the producing cells. Hence, by analyzing the expression patterns of Wnt3EGFP and PMTmApple, we were able to classify the dorsal regions of the cerebellum (dCe), the midbrain–hindbrain boundary (MHB), the brain midline (midbrain roof plate [mRP] and floor plate [FP]) and the epithalamus (Epi) as source regions of Wnt3, and the optic tectum (OT) and ventral regions of the cerebellum (vCe) as distal target regions. Subsequently, we probed how Wnt3 is distributed from the source to the target regions of the zebrafish brain by measuring its in vivo dynamics using fluorescence correlation spectroscopy (FCS) and fluorescence recovery after photobleaching (FRAP). FCS is a single molecule sensitive technique that statistically analyzes the intensity fluctuations in a small observation volume (~femtoliter scale) to generate an autocorrelation function (ACF), from which the diffusion coefficient and the concentration of the fluorescent molecules in the observation volume are accurately evaluated (Enderlein et al., 2005; Kim et al., 2007; Krichevsky and Bonnet, 2002; Magde et al., 1974). FRAP, on the contrary, is an ensemble technique that measures the dynamics of the fluorescent molecules in a large region of interest (~micrometer scale) based on the recovery of the fluorescence intensity in an irreversibly photobleached region (Klonis et al., 2002; Koppel et al., 1976). FCS and FRAP both measure molecular mobilities and have been shown to provide consistent results in vitro (Macháň et al., 2016). However, the global diffusion coefficient (Dglobal) measured from FRAP is significantly lower in comparison to its local diffusion coefficient (Dlocal) obtained from FCS for several morphogens in organisms (Müller et al., 2012; Müller et al., 2013). Here we study the local and global diffusion of Wnt3EGFP and identify the possible factors that leads to the discrepancy between its Dlocal and Dglobal.

Lastly, we monitored the in vivo interaction of Wnt3 with Fzd1, a potential target receptor, using fluorescence cross-correlation spectroscopy (FCCS) and calculated their binding affinity. In FCCS, the intensity fluctuations of two interacting molecules tagged with spectrally different fluorophores in an observation volume are cross-correlated, and the dissociation constant between the interacting species can be quantitatively determined in live cells and organisms (Ries et al., 2009; Schwille et al., 1997; Shi et al., 2009; Sudhaharan et al., 2009; Wang et al., 2016; Yavas et al., 2016). We observed that the co-receptor Lrp5 is essential for the interaction of Wnt3 with Fzd1. Our findings show that Wnt3EGFP spreads from its source to distal target regions by extracellular diffusion and the difference in local and global diffusion is due to tissue geometry, interactions with HSPG, and its receptors.

Results

Identifying the source and target regions for Wnt3

In order to identify the source and target regions of Wnt3, we used two transgenic lines: Tg(−4.0wnt3:Wnt3EGFP) and Tg(−4.0wnt3:PMTmApple). Tg(−4.0wnt3:Wnt3EGFP) is a functionally active Wnt3EGFP-expressing line driven by a 4 kb wnt3 promoter that positively regulates tissue growth in midbrain, MHB, and cerebellum (Teh et al., 2015). Tg(−4.0wnt3:PMTmApple) is a reporter line driven by the same 4 kb wnt3 promoter, expressing PMTmApple. Since the 4 kb wnt3 promoter contains most of the regulatory elements (Teh et al., 2015), Tg(−4.0wnt3:PMTmApple) is a faithful reporter of Wnt3 expression, which marks the plasma membrane of the Wnt3-producing cells. However, the localization of PMTmApple is restricted to its source cells, as it remains tethered to the inner leaflet of the plasma membrane. In contrast, the distribution pattern of Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) spans a broader range compared to PMTmApple in Tg(−4.0wnt3:PMTmApple), implying that Wnt3EGFP is transported from the source regions where it is produced to its distal target regions (Figure 1). The overlap in the expression of the two lines, therefore, identifies the source regions, and the difference demarcates the distal target regions.

Figure 1. Spatiotemporal expression of wnt3 promoter-driven Wnt3EGFP and PMTmApple.

Figure 1.

(A) Schematic illustration of the brain of a zebrafish embryo (dorsal view and lateral view). Expression profile of Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) line at (B) 24 hpf and (C) 48hpf. Expression profile of PMTmApple in Tg(−4.0wnt3:PMTmApple) line at (D) 24 hpf and (E) 48hpf. BV, brain ventricle; Ce, cerebellum; CP, choroid plexus; E, epiphysis; FP, floor plate; HB, hindbrain; MHB, midbrain–hindbrain boundary; mRP, midbrain roof plate; OT, optic tectum; r, rhombomere; RP, roof plate (spinal cord); SCO, sub-commissural organ. SCO and E are regions of the epithalamus (Epi). Images orientation: anterior to the left. Scale bar 30 μm.

The two transgenic lines were crossed [Tg(−4.0wnt3:Wnt3EGFP) × Tg(−4.0wnt3:PMTmApple)] and the expression of Wnt3EGFP and PMTmApple were sequentially recorded using a confocal microscope in their respective wavelength channels. First, the obtained image stacks were segmented using an automatic threshold algorithm (Zhu et al., 2016), and the colocalization of each pixel was evaluated based on the intensity correlation analysis (ICA), the distance weight, and intensity weight (Li et al., 2004; Zhu et al., 2016) to generate a pair of masks for the colocalized and non-colocalized pixels. Subsequently, color-coded heat maps were generated, indicating the contribution of each pixel to the overall colocalization at 24 and 48 hpf (Videos 1 and 2). Finally, using the colocalized and non-colocalized masks, volumetric images were constructed to distinguish the source and target regions of Wnt3 respectively. At 24 hpf, the source regions were MHB, dCe, and Epi, whereas the distal target regions were vCe and OT (Figure 2 and Video 3). The source regions at 48 hpf were mRP, FP, MHB, dCe, Epi, and some parts of the dorso-lateral optic tectum (dOT), while the distal target regions were vCe and ventral optic tectum (vOT) (Figure 3 and Video 4). With the source and target regions defined, we next quantified the dynamics of Wnt3EGFP and examined the mode of dispersal of Wnt3EGFP from its source to the distal target regions.

Figure 2. Wnt3 source and target regions at 24 hpf.

3D dorsal projection of Wnt3 (A) source regions at 24 hpf and (B) target regions at 24 hpf (top view). 3D ventral projection of Wnt3 (C) source regions at 24 hpf and (D) target regions at 24 hpf (bottom view). (E) 3D projection of Wnt3 source and target regions at 24 hpf (lateral view). See Video 3 for a detailed view. dCe, dorsal regions of cerebellum; Epi, epithalamus; MHB, midbrain–hindbrain boundary; OT, optic tectum; vCe, ventral regions of cerebellum. Images orientation: anterior to the left. Scale bar 30 μm.

Figure 2.

Figure 2—figure supplement 1. Fluorescence correlation spectroscopy (FCS) measurements of Wnt3EGFP and PMTmApple in the Wnt3 target regions at 24 hpf.

Figure 2—figure supplement 1.

Expression of (A) PMTmApple and (B) Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) × Tg(−4.0wnt3:PMTmApple) double transgenic embryos at 24 hpf. Representative autocorrelation function (ACF) for (C) PMTmApple and (D) Wnt3EGFP in the OT at 24 hpf. No ACFs were obtained for PMTmAPple in the target regions indicating an absence of mApple signal in these regions. Ce, cerebellum; MHB; midbrain–hindbrain boundary; OT, optic tectum. Images orientation: anterior to the left. Scale bar 30 μm.
Figure 2—figure supplement 2. Expression of EGFP in Tg(−4.0wnt3:EGFP) at 24 hpf.

Figure 2—figure supplement 2.

The expression of EGFP in Tg(-4.0wnt3:EGFP) closely mimics the expression of PMTmApple in Tg(−4.0wnt3:PMTmApple). Ce, cerebellum; MHB; midbrain–hindbrain boundary. Images orientation: anterior to the left. Scale bar 30 μm.
Figure 2—figure supplement 3. Expression of wnt3 transcripts and downstream wnt signaling transcription factor at 24 hpf.

Figure 2—figure supplement 3.

(A) Whole mount in situ hybridization (dorsal view) of wnt3 at 24 hpf. The expression pattern is similar to previously published results in Clements et al., 2009Duncan et al., 2015, and Teh et al., 2015. (B) Expression of NLS-mCherry in wnt reporter line Tg(7XTcf-Xla.Siam:NLS-Cherry) at 24 hpf. dCB, cerebellum; Epi, epithalamus; FP, floor plate; MHB, midbrain–hindbrain boundary; mRP, midbrain roof plate; OT, optic tectum. Orientation: anterior to left.

Figure 3. Wnt3 source and target regions at 48 hpf.

3D dorsal projection of Wnt3 (A) source regions at 48 hpf and (B) target regions at 48 hpf (top view). 3D ventral projection of Wnt3 (C) source regions at 48 hpf and (D) target regions at 48 hpf (bottom view). (E) 3D projection of Wnt3 source and target regions at 48 hpf (lateral view). See Video 4 for a detailed view. dCe, dorsal regions of cerebellum; Epi, epithalamus; FP, floor plate; MHB, midbrain–hindbrain boundary; mRP, midbrain roof plate; OT, optic tectum; vCe, ventral regions of cerebellum. Images orientation: anterior to the left. Scale bar 40 μm.

Figure 3.

Figure 3—figure supplement 1. Fluorescence correlation spectroscopy (FCS) measurements of Wnt3EGFP and PMTmApple in the Wnt3 target regions at 48 hpf.

Figure 3—figure supplement 1.

Expression of (A) PMTmApple and (B) Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) × Tg(−4.0wnt3:PMTmApple) double transgenics at 48 hpf. Representative autocorrelation function (ACF) for (C) PMTmApple and (D) Wnt3EGFP in the OT at 48 hpf. No ACFs were obtained for PMTmAPple in the target regions indicating an absence of mApple signal in these regions. Ce, cerebellum; MHB, midbrain–hindbrain boundary; OT, optic tectum. Images orientation: anterior to the left. Scale bar 30 μm.
Figure 3—figure supplement 2. Expression of EGFP in Tg(−4.0wnt3:EGFP) at 48 hpf.

Figure 3—figure supplement 2.

The expression of EGFP in Tg(-4.0wnt3:EGFP) closely mimics the expression of PMTmApple in Tg(−4.0wnt3:PMTmApple). Ce, cerebellum; MHB, midbrain–hindbrain boundary; OT, optic tectum. Images orientation: anterior to the left. Scale bar 30 μm.
Figure 3—figure supplement 3. Expression of wnt3 transcripts and downstream wnt signaling transcription factors at 48 hpf.

Figure 3—figure supplement 3.

(A) Whole mount in situ hybridization (dorsal view) of wnt3 at 48 hpf. The expression pattern is similar to previously published results in Clements et al., 2009Duncan et al., 2015, and Teh et al., 2015. (B) Expression of NLS-mCherry in wnt reporter line Tg(7XTcf-Xla.Siam:NLS-Cherry) at 48 hpf. dCB, cerebellum; Epi, epithalamus; FP, floor plate; MHB, midbrain–hindbrain boundary; mRP, midbrain roof plate; OT, optic tectum. Orientation: anterior to left.

Video 1. Colocalization of Wnt3EGFP and PMTmApple in Tg(−4.0wnt3:Wnt3EGFP) × Tg(−4.0wnt3:PMTmApple) at 24 hpf.

Download video file (381.9KB, mp4)

Video 2. Colocalization of Wnt3EGFP and PMTmApple in Tg(−4.0wnt3:Wnt3EGFP) × Tg(−4.0wnt3:PMTmApple) at 48 hpf.

Download video file (1.1MB, mp4)

Video 3. Source (red) and distal target (green) regions of Wnt3 at 24 hpf.

Download video file (9.6MB, mp4)

Video 4. Source (red) and distal target (green) regions of Wnt3 at 48 hpf.

Download video file (13.3MB, mp4)

Characterizing the in vivo dynamics of Wnt3EGFP

Wnt3EGFP was detected in the fourth brain ventricle (BV), and along the cell borders in midbrain, MHB, and hindbrain (Figure 4A). In the BV, Wnt3EGFP diffuses freely with a diffusion coefficient of 54.6 ± 11.3 µm2/s. In addition, a slow diffusing fraction with a diffusion coefficient of 4.8 ± 3.4 µm2/s was also detected in the BV. The ACF were fit using a 3D-2particle-1triplet model for Wnt3EGFP in the BV, as determined by Bayes inference-based model selection (Sun et al., 2015; Teh et al., 2015) (see Materials and methods). In the cerebellum, MHB, and optic tectum, the cells are densely packed at 24 hpf and 48hpf, and there is no apparent extracellular space resolved within the limits of our microscopes (~200 nm). It is thus not possible to determine from imaging alone whether Wnt3EGFP is present in the interstitial spaces. We therefore use an indirect approach and measure the molecular mobility of Wnt3EGFP at the borders between neighboring cells using FCS (Figure 4B). As diffusion coefficients on membranes and in aqueous solution differ by at least one order of magnitude if not more, they can be easily distinguished, and the presence of a freely diffusible species can be identified. For FCS measurements along the cell borders, we used a 2D-2particle-1triplet fit model (Equation 7 in Materials and methods) . The fact that data can be fit with a 2D model most likely indicates that Wnt3EGFP either diffuses on the membrane or in the narrow interstitial spaces that have a very small extent (<200 nm) compared to the axial extent of the confocal volume (~1 μm). The two detected diffusive components comprise a slow component, which was the dominant fraction (Fslow ~0.6 ± 0.05), with a diffusion coefficient (Dslow) of 0.6 ± 0.3 µm2/s and a fast component with a diffusion coefficient (Dfast) of 27.6 ± 3.9 µm2/s (Figure 4E). The diffusion coefficients of proteins range roughly between 0.1 and 2 µm2/s in cell membranes and depend on their localization and interactions within the membrane. As shown in our previous studies, Wnt3 is associated with lipid domains on the membrane and is influenced by various interventions that change the lipid content of membranes in cells and in vivo (Azbazdar et al., 2019; Ng et al., 2016; Sezgin et al., 2017). Therefore, the slow component likely represents the fraction of Wnt3EGFP on the membrane. On the other hand, the fast component is too fast to be attributed to diffusion within the plasma membrane. Note, however, that we cannot unambiguously assign the fast diffusion coefficient to Wnt3EGFP in the interstitial spaces. The confocal volume for FCS measurements on the membrane also spans a portion of the intracellular cytosol. Hence, a fraction of Wnt3EGFP within the cytosol could have contributed to the fast diffusion. Therefore, to check whether Wnt3EGFP diffuses in the extracellular spaces, we tested whether the fast diffusion coefficient is susceptible to changes in the interstitial spaces.

Figure 4. Characterizing the dynamics of Wnt3EGFP and secEGFP using fluorescence correlation spectroscopy (FCS).

(A) Expression of Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) at 48 hpf. (B) Representative autocorrelation function (ACF; dots) and fitting (line) of a Wnt3EGFP measurement at a cell boundary. (C) Expression of secEGFP in the zebrafish brain at 48 hpf. (D) Representative ACF (dots) and fitting (line) of a secEGFP measurement at a cell boundary. (E) Table showing diffusion coefficients of the fast component (Dfast), slow component (Dslow) and the fraction of slow component (Fslow) for Wnt3EGFP and secEGFP measured by FCS. Measurements were performed in the cell borders of Ce, MHB, and OT; and in the BV. Data are mean ± SD; N = No of measurements. BV, brain ventricle; Ce, cerebellum; MHB, midbrain–hindbrain boundary; OT, optic tectum. Images orientation: anterior to left. Scale bar 30 μm.

Figure 4—source data 1. Diffusion coefficients of Wnt3EGFP and secEGFP at cell borders and in the brain ventricle.

Figure 4.

Figure 4—figure supplement 1. Expression and dynamics of secEGFP under 4 kb wnt3 promoter.

Figure 4—figure supplement 1.

(A) Expression of secEGFP under wnt3 promoter in the zebrafish brain at 48hpf. (B) Representative fluorescence correlation spectroscopy measurement of secEGFP under wnt3 promoter with a diffusion coefficient of 57.1 μm2/s. (C) Representative fluorescence recovery after photobleaching recovery curve of secEGFP under wnt3 promoter with a diffusion coefficient of 16.3 μm2/s. Orientation: anterior to the left. Scale bar 30 μm.

Wnt3EGFP spreads extracellularly in the interstitial spaces

As Wnts are highly hydrophobic molecules, they tend to aggregate after being secreted into the extracellular milieu, which would limit them to autocrine and juxtacrine signaling (Fuerer et al., 2010). However, the expression of Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) was detected at a distance (~50–150 µm) from the recognized source regions, implying long-range travel. Hence, we examined how Wnt3EGFP spreads across the zebrafish brain, and whether it chooses the extracellular route. Since the cells are tightly packed at late stages (after 24 hpf) of the zebrafish embryo, we first verified the existence of the interstitial spaces at these late stages. We injected secreted EGFP mRNA (secEGFP), the secretory peptide of Fibroblast growth factor 8a (Fgf8a) tagged with EGFP, at the one-cell stage and imaged the zebrafish brain at 48 hpf. The secEGFP construct is targeted for extracellular secretion after its translation in the cytoplasm and it is a marker for interstitial spaces. We observed the expression of secEGFP along the cell boundaries of the zebrafish brain even at tightly packed stages (≥24 hpf) and in the BV (Figure 4C). When the dynamics for secEGFP was measured using FCS, we obtained a D of 57.9 ± 14.4 µm2/s along the cell boundaries and a D of 87.5 ± 11.3 µm2/s in the BV (Figure 4D,E). These values are independent of whether secEGFP is injected as mRNA or whether it is expressed under the control of the 4 kb wnt3 promoter (Figure 4—figure supplement 1). As secEGFP does not bind to the cell membrane, this indicates its diffusion in the extracellular spaces, consistent with the fast diffusion coefficient measured (Müller et al., 2012; Müller et al., 2013).

As mentioned above, we were unable to unambiguously assign Wnt3EGFP diffusion to its presence in interstitial spaces. Thus, we evaluated the effects of HSPG, a cell surface, and extracellular matrix protein which should influence only molecules in interstitial spaces, on the dynamics of Wnt3EGFP. Since the interactions of Wnts with HSPG and the significance of HSPG in the activity of Wnts are well established (Fuerer et al., 2010; Kirkpatrick and Selleck, 2007; Mii et al., 2017), we treated the Tg(−4.0wnt3:Wnt3EGFP) embryos with heparinase to disrupt HSPG and measured the dynamics of Wnt3EGFP. Injecting heparinase at the one-cell stage showed impaired gastrulation, so heparinase along with a high molecular weight fluorescent dextran (70,000 MW Dextran-TRITC) was co-injected in the BV of 48 hpf Wnt3EGFP expressing embryos. Since the presence of fluorescent dextran was detected along cell boundaries of the cerebellum and OT, we inferred that heparinase (∼42 kDa) also diffused into the interstitial spaces from the BV (Table 1—source data 1). Confocal FCS measurements revealed that while Dslow of Wnt3EGFP for heparinase treated and untreated embryos remained the same, Dfast for heparinase treated embryos was almost twofold higher (Dfast = 43.4 ± 7.6 µm2/s) in comparison with untreated embryos (Dfast = 24.7 ± 4.8 µm2/s) (Table 1). Additionally, we also treated Wnt3EGFP embryos with surfen, a quinolone-based derivative that exhibits heparin neutralizing activity and antagonizes heparan sulfate–protein interactions (Naini et al., 2018). Similar to heparinase treatment, surfen-treated Wnt3EGFP embryos had a higher Dfast of 42.0 ± 6.9 µm2/s whereas Dslow remained unchanged (0.5 ± 0.3 µm2/s) (Table 1). As Wnts are known to travel in the extracellular spaces by constant binding and unbinding to HSPG (Yan and Lin, 2009), the change in diffusion coefficient upon HSPG cleavage is only seen for the fast component in the extracellular spaces and not the slow component.

Table 1. Influence of heparan sulfate proteoglycans on the dynamics of Wnt3EGFP, LynEGFP, and secretedEGFP at 48 hpf. Data are mean ± SD.

Table 1—source data 1. Tg(−4.0wnt3:Wnt3EGFP) embryos treated by heparinase and surfen.
(A) The expression of Wnt3EGFP after heparinase treatment. (B) Distribution of Dextran-TRITC coinjected with heparinase in the BV of Tg(−4.0wnt3:Wnt3EGFP) embryo. (C) Expression of Wnt3EGFP after surfen treatment. BV, brain ventricle; Ce, cerebellum. Images orientation: anterior to the left. Scale bar 50 μm.
Table 1—source data 2. Individual fluorescence correlation spectroscopy measurements of Wnt3EGFP, LynEGFP, and secEGFP embryos before and after heparan sulfate proteoglycan disruption.
Sample Dfast (µm2/s) Dslow (µm2/s) Fslow No. of measurements
Wnt3EGFP 24.7 ± 4.8 0.6 ± 0.3 0.6 ± 0.02 47
Wnt3EGFP + heparinase 43.4 ± 7.6 0.4 ± 0.2 0.6 ± 0.04 63
Wnt3EGFP + surfen 42.0 ± 6.9 0.5 ± 0.3 0.6 ± 0.08 30
LynEGFP 39.1 ± 11.2 2.2 ± 0.6 0.7 ± 0.04 29
LynEGFP + heparinase 40.1 ± 9.5 2.7 ± 0.7 0.6 ± 0.04 35
LynEGFP + surfen 41.4 ± 6.9 3.1 ± 0.9 0.7 ± 0.06 18
SecEGFP 59.4 ± 9.4 - - 30
SecEGFP + heparinase 56.9 ± 9.7 - - 30
SecEGFP + surfen 53.5 ± 8.5 - - 18

As controls, we measured the effects of heparinase and surfen treatment on the diffusion of secEGFP and LynEGFP (a non-functional membrane tethered tyrosine kinase) as they are not known to interact with HSPG. When secEGFP embryos were treated with heparinase or surfen, we observed no changes in D compared to the untreated embryos implying that increase in Dfast for Wnt3EGFP was not due to clearing up of the interstitial spaces (Table 1). For LynEGFP in Tg(−8.0cldnB:LynEGFP), we obtained a slow component with a Dslow of 2.2 ± 0.6 µm2/s and a fast component with a Dfast of 39.1 ± 11.2 µm2/s. As the Dslow is within the range of diffusion coefficients observed for proteins on the membrane (0.1–2 µm2/s), the Dslow corresponds to the membrane diffusing component while Dfast represents a putative cytosolic fraction. When LynEGFP embryos were treated with heparinase or surfen, we did not observe any changes in Dfast or Dslow, confirming that neither membrane nor cytosolic diffusion is influenced upon HSPG disruption (Table 1). Since we observe a twofold increase in Dfast only for Wnt3EGFP, but not for secEGFP and LynEGFP, upon HSPG cleavage our results suggest an extracellular distribution of Wnt3EGFP regulated by constant binding and unbinding with HSPG.

To substantiate our results, we studied the global diffusion of Wnt3EGFP using FRAP. As FRAP measures mobility over a range of several cell diameters, it is an ideal tool to investigate whether Wnt3 can diffuse extracellularly or by other slower cellular mechanisms. We irreversibly photobleached a region of the zebrafish brain in Tg(−4.0wnt3:Wnt3EGFP) embryos, and observed the rate of recovery in the photobleached region. On analyzing the FRAP curve for Wnt3EGFP, two components with different time constants were obtained: a fast component with a time constant (τfast) of 5–8 min and a slow component with a time constant τslow >40 min. The fast component likely denotes the recovery due to diffusion in the extracellular spaces as cell-based mechanisms would have much slower recovery rates. The slow component likely represents the recovery due to production of the fluorescent protein as the recovery time corresponds to the time taken for translation and maturation of the fluorophore. The mobile fraction (Fm) of Wnt3EGFP evaluated from FRAP was 0.3–0.4 with an apparent global diffusion coefficient (Dglobal) of 0.5 ± 0.2 µm2/s (Figure 5), almost 40–100 times slower when compared to the local diffusion coefficient obtained from FCS (Dlocal = 24.7 ± 4.8 µm2/s). The recovery rates for Wnt3EGFP were similar at the source (Figure 5E) and at distal target regions (Figure 5—figure supplement 1). When HSPG were disrupted, faster recovery was observed (τfast ~2.5 to 3 min) with an increase of a factor ~2–3 in Dglobal (1.3 ± 0.5 µm2/s) (Figure 5—figure supplement 2), indicating that Wnt3EGFP diffusion is slowed down by transient interactions with HSPG in the extracellular spaces. When FRAP was performed for secEGFP in the same region of the zebrafish brain, secEGFP showed rapid recovery with a τfast of ~30 s and a Dglobal of 13 ± 4 µm2/s (Fm of 0.7–0.9), almost three to five times slower than its Dlocal measured from FCS (55–60 µm2/s) (Figure 5—figure supplement 3). On the other hand, PMTmApple showed no recovery within the same measurement time of the experiment (40 min) (Figure 5—figure supplement 4). Although the source regions continuously produce PMTmApple, the generation of novel PMTmApple involves transcription, translation, and post-translational chromophore maturation (maturation time for mApple is ~30 min). Since PMTmApple is tethered to the cell membrane, no recovery is observed after photobleaching of PMTmApple before 30 min. Overall, the FRAP results substantiate our hypothesis that Wnt3EGFP achieves long-range distribution in the zebrafish brain by diffusing in the extracellular spaces with constant binding and unbinding to HSPG.

Figure 5. Representative fluorescence recovery of Wnt3EGFP at 48 hpf after photobleaching.

(A) Expression of Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) at 48 hpf before photobleaching. (B) Photobleached region of Wnt3EGFP. (C) Recovery of fluorescence intensity in the bleached region due to diffusion of molecules from the neighboring unbleached regions. (D) Fluorescence recovery curve for Wnt3EGFP with a time constant (τfast) of ~5 min and a mobile component fraction (Fm) of ~0.35. The average apparent global diffusion coefficient (Dglobal) measured for Wnt3EGFP was 0.5 ± 0.2 μm2/s (N = 11). Fluorescence recovery after photobleaching for Wnt3EGFP at a distal target site showed similar recovery dynamics (Figure 5—figure supplement 1) whereas recovery after heparan sulfate proteoglycan disruption showed faster recovery (Figure 5—figure supplement 2). Orientation: anterior to the left. Scale bar 30 μm.

Figure 5—source data 1. Individual fluorescence recovery after photobleaching measurements of Wnt3EGFP and secEGFP embryos.

Figure 5.

Figure 5—figure supplement 1. Representative fluorescence recovery of Wnt3EGFP at a distal target site after photobleaching.

Figure 5—figure supplement 1.

(A) Expression of Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) 48 hpf before photobleaching. (B) Photobleached region of Wnt3EGFP. (C) Recovery of fluorescence intensity in the bleached region due to diffusion of molecules from the neighboring unbleached regions. (D) Fluorescence recovery curve for Wnt3EGFP with a time constant (τfast) of ~6.5 min and an apparent global diffusion coefficient (Dglobal) of 0.47 μm2/s. Scale bar 30 μm. 
Figure 5—figure supplement 2. Representative fluorescence recovery of Wnt3EGFP at a distal target site after heparan sulfate proteoglycan (HSPG) disruption.

Figure 5—figure supplement 2.

(A) Expression of Wnt3EGFP in Tg(−4.0wnt3:Wnt3EGFP) before photobleaching in HSPG disrupted embryos. (B) Photobleached region of Wnt3EGFP. (C) Recovery of fluorescence intensity in the bleached region due to diffusion from the neighboring unbleached regions. (D) Fluorescence recovery curve for Wnt3EGFP with a recovery time (τfast) of ~1.5–2.5 min and a Dglobal of ~1.5–3.75 μm2/s, which is approximately two to three times faster than untreated embryos as shown in Figure 5. Images orientation: anterior to the left. Scale bar 30 μm.
Figure 5—figure supplement 3. Representative fluorescence recovery of secEGFP after photobleaching at 48 hpf.

Figure 5—figure supplement 3.

(A) Expression of secEGFP before photobleaching. (B) Photobleached region of secEGFP. (C) Recovery of fluorescence intensity in the bleached region due to diffusion of molecules from the neighboring unbleached regions. (D) Fluorescence recovery curve for secEGFP with a quick recovery time (τfast) of ~45 s and a fraction of mobile component (Fm) of ~0.85. The average global diffusion coefficient (Dglobal) measured for secEGFP was 13 ± 4 μm2/s. Images orientation: anterior to the left. Scale bar 30 μm.
Figure 5—figure supplement 4. Representative fluorescence recovery of PMTmApple after photobleaching at 48 hpf.

Figure 5—figure supplement 4.

(A) Expression of PMTmApple in Tg(−4.0wnt3:PMTmApple) at 48 hpf before photobleaching. (B) Photobleached region of PMTmApple. (C) No recovery of fluorescence intensity in the bleached region as PMT remains tethered to the cell membrane and does not diffuse. (D) Fluorescence recovery curve for PMTmApple. Images orientation: anterior to the left. Scale bar 30 μm.

The in vivo interactions of Wnt3 with Fzd1 receptor depend on the expression of lrp5 co-receptor

Apart from the interactions of signaling molecules with the extracellular matrix proteins, the transient trapping of ligands by their receptors also shapes their distribution profile (Müller et al., 2013). For instance, the transient binding of Nodals to their receptor Acvr2b and co-receptor Oep (Lord et al., 2019; Wang et al., 2016), Hedgehog to the 12-transmembrane protein Dispatched (Callejo et al., 2011), and Wingless to the Fzd receptor (Baeg et al., 2004) influence their respective distributions and gradient kinetics. Hence, it is critical to evaluate the binding affinity of Wnt3 with its target receptors to understand its signaling range and action. Although the binding affinities for different Wnt ligands and Fzd receptors were quantified, they were limited to biochemical analysis on mammalian cell lines (Dijksterhuis et al., 2015). The dynamics and conformation of proteins might differ significantly in vivo (Lipinski and Hopkins, 2004), and quantitative analysis of Wnt-Fzd interactions in live organisms is still lacking. Since in vitro genetic and biochemical assays reported that Wnt3 interacts strongly with Fzd1 (Dijksterhuis et al., 2015), we investigated the in vivo Wnt3EGFP-Fzd1mApple interaction and measured its binding affinity. For this purpose, we generated a transgenic line Tg(−4.0wnt3:Fzd1mApple) expressing Fzd1mApple, crossed it with the Wnt3EGFP expressing line, and studied in vivo interactions using quasi-PIE FCCS (Figure 6A,B). Quasi-PIE FCCS is an extension of FCCS, where the sample is simultaneously illuminated by a pulsed laser line and a continuous wave laser line of different wavelengths (Padilla-Parra et al., 2011; Yavas et al., 2016). This approach allows us to filter background, spectral cross-talk, and detector after pulsing while computing the auto- and cross-correlation functions (Kapusta et al., 2012). When quasi-PIE FCCS measurements were performed in embryos expressing Wnt3EGFP and Fzd1mApple, we obtained positive cross-correlations between the two channels, indicating the in vivo interaction of Wnt3EGFP with Fzd1mApple (Figure 6C). As a positive control, we used embryos expressing PMT-mApple-mEGFP, and as negative control, we used embryos expressing Wnt3EGFP and PMTmApple by crossing their respective transgenic lines (Figure 6—figure supplement 1). The auto- and cross-correlations were then fitted with Equation (7), and the binding affinity was measured according to Equation (12) (see Materials and methods). We obtained an apparent dissociation constant (Kd) of 112 ± 15 nM indicating that Wnt3EGFP binds strongly with Fzd1mApple in vivo (Figure 6D). The measured in vivo Kd for Wnt3-Fzd1 is comparable with the in vitro Kd values reported for Wnts with Fzd1, which were in the range of 15–90 nM (Dijksterhuis et al., 2015).

Figure 6. Investigation of in vivo Wnt3-Fzd1 binding by FCCS.

Expression of (A) Wnt3EGFP and (B) Fzd1mApple in the double transgenic [Tg(−4.0wnt3:Wnt3EGFP)×Tg (−4.0wnt3:Fzd1mApple)] (anterior to the left). (C) Representative auto- and cross-correlation functions (dots) and fittings (lines) of a Wnt3EGFP-Fzd1mApple measurement at the indicated region. The cross-correlation function indicates Wnt3EGFP interacts with Fzd1mApple in vivo. (D) Determination of apparent dissociation constant (Kd) for Wnt3-Fzd1 interaction in vivo. Cg, Cr, and Cgr represents the concentration of unbound Wnt3EGFP, unbound Fzd1mApple, and bound Wnt3-Fzd1 molecules respectively. The estimated apparent Kd [Kd = (Cg × Cr)/Cgr] for Wnt3-Fzd1 in vivo is 112 ± 15 nM (N = 23; R2 = 0.85). (E) Representative auto- and cross-correlation functions (dots) and fittings (lines) of a Wnt3EGFP-Fzd1mApple measurement after knocking down lrp5. No cross-correlation indicates Wnt3-Fzd1 interaction is abolished after knockdown of lrp5. Scale bars 30 μm.

Figure 6—source data 1. Apparent dissociation constant (Kd) calculation for Wnt3-Fzd1 interaction and fluorescence recovery after photobleaching recovery rates after lrp5 knockdown.

Figure 6.

Figure 6—figure supplement 1. Representative FCCS measurements for positive and negative control in zebrafish.

Figure 6—figure supplement 1.

Representative auto- and cross-correlation functions for (A) PMT-mApple-mEGFP which is a positive control showing a clear cross-correlation and (B) negative control PMT-mApple and Wnt3-EGFP showing no cross-correlations.
Figure 6—figure supplement 2. Role of Lrp5 coreceptor in Wnt3-Fzd1 binding.

Figure 6—figure supplement 2.

(A) Representative FCCS measurement for Wnt3EGFP and Fzd1mApple in regions with no Lrp5 expression (ventral cerebellum). No cross-correlations obtained outside midbrain–hindbrain boundary and dorsal cerebellum indicating role of Lrp5 in Wnt3-Fzd1 interaction. (B) Knocking down lrp5 morpholino resulting in deformed optic tectum (OT) and cerebellum (Ce) of the zebrafish brain. (C) Wnt3EGFP after treatment with negative control lrp5 mismatch MO with five nucleotide substitutions showing normal brain development and (D) retaining cross-correlations between Wnt3EGFP and Fzd1mApple.
Figure 6—figure supplement 3. Representative fluorescence recovery of Wnt3EGFP in lrp5 knocked-down embryos at 48 hpf after photobleaching.

Figure 6—figure supplement 3.

(A) Expression of Wnt3EGFP before photobleaching. (B) Photobleached region of Wnt3EGFP. (C) Recovery of fluorescence intensity in the bleached region due to diffusion of molecules from the neighboring unbleached regions. (D) Fluorescence recovery curve for Wnt3EGFP with a recovery time (τfast) of ~150 s and a fraction of mobile component (Fm) of ~0.5. The average global diffusion coefficient (Dglobal) measured for Wnt3EGFP after lrp5 knockdown was 2.8 ± 0.8 μm2/s. Images orientation: anterior to the left. Scale bar 30 μm.

Interestingly, Wnt3EGFP-Fzd1mApple interactions were only detected in the MHB and the dCe of the zebrafish brain at 48 hpf. No interactions were detected in the vCe or OT despite detecting Wnt3EGFP and Fzd1mApple in these regions (Figure 6—figure supplement 2A). Since the expression of the co-receptor lrp5 corresponds to the specific regions where we detected interactions (Willems et al., 2015), we hypothesized that Lrp5 is necessary for the in vivo binding of Wnt3 to Fzd1. To test this, we knocked down the expression of lrp5 using morpholinos (Mo) and checked for Wnt3EGFP-Fzd1mApple interactions in the MHB and dCe. We used lrp5MoUp, which targets the Exon2-Intron2 splice junction, and lrp5MoDown that targets Intron2-Exon3 splice junctions to knockdown lrp5. As a control, we used a mismatch morpholino containing five nucleotide substitutions (see Materials and methods for details). The efficacy of morpholinos was previously characterized in Willems et al., 2015. Upon knockdown of lrp5, we observed defective brain development (Figure 6—figure supplement 2B) and we did not detect any cross-correlations in MHB and dCe (Figure 6E). However, cross-correlations were obtained in the corresponding regions for untreated embryos and embryos treated with mismatch morpholino (Figure 6—figure supplement 2C,D). When we performed FRAP for Wnt3EGFP after lrp5 knockdown, we obtained a faster recovery of ~1.5 min for Wnt3EGFP in the photobleached region with a Dglobal of 2.8 ± 0.8 µm2/s, indicating that receptor binding slows Wnt3EGFP diffusion by a factor ~5–6 (Figure 6—figure supplement 3). These results suggest that the co-receptor Lrp5 is essential for in vivo Wnt3EGFP-Fzd1mApple interaction and that this interaction influences Wnt3EGFP diffusion.

Discussion

Symmetry breaking and the development of an embryo into an organism require a finely balanced but robust position-sensitive control of cell behavior and differentiation. This is achieved by signaling molecules that are expressed in well-defined source regions and distribute to target tissues where they are recognized by their cognate receptors. Wnts are a class of molecules that fulfill this function and are involved in cell division, cell migration, apoptosis, embryonic axis induction, cell fate determination, and maintenance of stem cell pluripotency (Clevers and Nusse, 2012; Logan and Nusse, 2004). Misregulation of this process leads to developmental defects and diseases, including cancer. In this work, we investigated the in vivo action mechanism of Wnt3, a member of this family that is involved in the proliferation and differentiation of neural cells, with particular attention to the differentiation of source and target regions, the mode of transport, and the recognition of Wnt3 by its target receptor.

First, we analyzed the colocalization of Wnt3EGFP and PMTmApple expression in the double transgenic [Tg(−4.0wnt3:Wnt3EGFP) × Tg(−4.0wnt3:PMTmApple)] to map Wnt3 source and distal target regions at 24 hpf and 48 hpf. We categorized the MHB, Epi, and dCe as the source regions for Wnt3 at 24 hpf. We observed that the source regions expanded with time to include the mRP, FP, and dorso-lateral OT as source at 48 hpf. Interestingly, earlier studies had documented these regions as the primary signaling centers that control the development of the central nervous system (CNS). The brain midline, comprising of the roof plate and FP, represent the signaling glia that acts as the source of several secreted signals involved in neuronal specification (Chizhikov et al., 2006; Jessell, 2000; Kondrychyn et al., 2013). Chizhikov and Millen, 2005 provided a comprehensive overview on how the roof plate governs the specification of the hindbrain, diencephalon, telencephalon, and spinal cord by producing BMP and Wnt proteins. Similarly, the importance of the MHB (also known as the isthmic organizer) in the morphogenesis of the zebrafish brain is also well studied (Gibbs et al., 2017; Raible and Brand, 2004; Wurst and Bally-Cuif, 2001). Our results, at a molecular level, corroborate these functional studies, which examine the role of these signaling centers in coordinating brain development by producing critical signaling molecules.

As we identified the Wnt3 source regions based on the colocalization analysis of Wnt3EGFP and PMTmApple fluorescence signal, any weak mApple signal that is undetected by confocal imaging might underestimate the full range of Wnt3 source regions. Hence, we used FCS, a single molecule sensitive technique, to check if any weak PMTmApple intensity fluctuations are detected outside the classified source regions. When we performed FCS in the double transgenic [Tg(−4.0wnt3:Wnt3EGFP) × Tg(−4.0wnt3:PMTmApple)] embryos, we obtained autocorrelation functions for Wnt3EGFP but not for PMTmApple in the OT and ventral regions (Figure 2—figure supplement 1 and Figure 3—figure supplement 1). Furthermore, the expression pattern of PMTmApple closely resembles the expression of Tg(−4.0wnt3:EGFP) (Figure 2—figure supplement 2 and Figure 3—figure supplement 2), a reporter line driven by the 4 kb wnt3 promoter expressing cytosolic EGFP in domains of endogenous wnt3 transcripts (Clements et al., 2009; Duncan et al., 2015; Teh et al., 2015; Figure 2—figure supplement 3, Figure 3—figure supplement 3). The expression of egfp transcripts also closely mirrors the expression of wnt3 transcripts, implying that the 4 kb wnt3 promoter contains most, if not all, regulatory elements (Teh et al., 2015). While these results suggest that Tg(−4.0wnt3:PMTmApple) is indeed a faithful reporter of Wnt3 expression, we cannot exclude the possibility of underestimating the extent of Wnt3 source regions.

Our approach based on the analysis of the distribution of proteins in vivo enabled us to validate not only the source regions but also the obtained information regarding the distribution of signaling proteins in live samples. We identified the vCe and OT as the target regions to where Wnt3EGFP is transported. These identified target regions correspond to the 7 T-cell factor (TCF) responsive elements-driven nuclear localization sequence mCherry (NLS-mCherry) expression in the wnt reporter line Tg(7xTcf-Xla.Siam:NLS-mCherry) that is activated by endogenous Wnt ligands (Moro et al., 2012; Figure 2—figure supplement 3 and Figure 3—figure supplement 3). However, the whole list of Wnt3 target sites could be longer. Recently, it was shown that Wnt5A transported in the cerebrospinal fluid regulates the development of the hindbrain (Kaiser et al., 2019). Since we also detect Wnt3EGFP diffusing in the BV (Teh et al., 2015), further investigation is required to detect additional less obvious target sites. Nevertheless, the characterization of Wnt3 source and target regions of this work clearly indicates the presence of discrete Wnt3-producing and -receiving cells in the developing brain of zebrafish embryos.

Second, we investigated the transport mechanism of Wnt3EGFP in the zebrafish brain by measuring its local and global diffusion coefficients using FCS and FRAP respectively. The transport mechanism not only influences signaling and function, but is of particular interest for Wnts as it is not clear how they can distribute over long distances despite their hydrophobic nature. Using FCS, we first quantified the in vivo diffusion of Wnt3EGFP along the cell boundaries and in the BV. In the BV, we found a fast diffusing component with Dfast of 54.6 ± 11.3 µm2/s and a slow component with Dslow of 4.8 ± 3.4 µm2/s (Figure 4E). The first component is similar to secEGFP and consistent with freely diffusing Wnt3EGFP, or at best Wnt3EGFP in a small complex, e.g. with a shuttling protein that hides the hydrophobic Wnt3 moiety and prevents its aggregation. The second component is much slower and hints at Wnt3EGFP associated with larger protein or lipid complexes and would be consistent with either exosomes or protein transport complexes. It will be interesting to address the exact nature of the aggregation and/or complexation state of Wnt3 in future studies. At the cell boundaries, we found two diffusive components for all Wnt3EGFP measurements: a slow component that is consistent with membrane diffusion (Dslow = 0.6 ± 0.3 µm2/s) and a fast component (Dfast = 27.6 ± 3.9 µm2/s) much closer to the diffusion coefficient seen for secEGFP (D = 57.9 ± 14.4 µm2/s). Due to resolution limitations of FCS, we could not unambiguously attribute this component to secreted Wnt3EGFP, as cytosolic Wnt3EGFP could also contribute to the fast diffusing component. Since Wnts has been shown to interact with HSPG (Fuerer et al., 2010; Kirkpatrick and Selleck, 2007; Mii et al., 2017), we disrupted HSPG by heparinase and surfen treatment, which should influence the diffusion of only extracellular Wnt3EGFP but not the putative cytosolic component. In subsequent measurements, Dfast for Wnt3EGFP, but not for secEGFP and LynEGFP, increased almost twofold upon HSPG perturbation indicating that Wnt3EGFP indeed spreads by extracellular diffusion. If Wnt3EGFP (~73 kDa) diffuses freely similar to secEGFP (~33 kDa), one would expect a 30% difference in their diffusion coefficient (D is inversely proportional to the cube root of the mass). As Wnt3EGFP interacts with HSPG it is slowed down in its movement. Thus it diffuses a factor ~2 (=57/28) slower than secEGFP. However, after HSPG disruption, secEGFP and Wnt3EGFP differ by a factor of 60/46 = 1.3 as expected. This implies that the diffusion coefficient for Wnt3EGFP increases as it is no longer retarded by HSPG, and not due to clearing up of free space. Recently, consistent with our experiments, McGough et al., 2020 demonstrated how glypicans, a major family of HSPG, enable the spreading of Wingless in Drosophila by shielding the Wnt lipid moiety. Overall, these results are in line with Wnt transport models that support the extracellular distribution by HSPG (Baeg et al., 2001; Han et al., 2005; Mii et al., 2017; Yan and Lin, 2009). Similar results were also reported for Fgf8, which establishes a concentration gradient in zebrafish embryos by extracellular diffusion (Yu et al., 2009).

FRAP experiments conducted at multiple cell diameters removed from the source region corroborate these results. Fluorescence recovery took place in 5–8 min for Wnt3EGFPindicating transport over long distances. However, the estimated apparent global diffusion coefficient of Wnt3EGFP (Dglobal) was only 0.5 ± 0.2 µm2/s, a factor ~40–100 lower than the local diffusion coefficient in the interstitial spaces measured by FCS (27.6 ± 3.9 µm2/s) (Figure 5). This is in stark contrast to secEGFP Dglobal which was estimated to be 13 ± 4 µm2/s and was reduced by only about a factor ~3–5 compared to FCS measurements of the same molecule with Dlocal of 57.9 ± 14.4 µm2/s (Figure 5—figure supplement 1). As secEGFP is only a secreted control that diffuses in the same environment as Wnt3EGFP, it does not interact with HSPG or receptors, and the smaller reduction in the global versus the local diffusion coefficient for secEGFP is likely an effect of tortuosity (Müller et al., 2013). However, the much larger reduction of the global diffusion coefficient for Wnt3EGFP calls for a different explanation, possibly including transient binding to its receptors and HSPG (Müller et al., 2013). Subsequent experiments showed that HSPG disruption by heparinase or surfen increased Wnt3EGFP diffusion by a factor ~2 (Table 1, Figure 5—figure supplement 2), and lrp5 knockdown increased the Wnt3EGFP Dglobal by a factor ~5–6 (Figure 6—figure supplement 3). Overall this accounts for a reduction in global Wnt3EGFP diffusion by at least a factor 30–60, consistent with the 40–100-fold reduction seen by the comparison of short-range (FCS) and long-range (FRAP) diffusion of Wnt3EGFP in native conditions. Hence, our FCS and FRAP results are consistent and collectively implicate the extracellular diffusion of Wnt3EGFP mediated by HSPG and receptor binding to accomplish long-range dispersal in the developing zebrafish brain.

However, we cannot discount the possibility that Wnt3 might additionally assume other modes of spreading. It is possible that carrier proteins or exosomes also shuttle Wnt3 in the zebrafish brain as would be consistent with the second slow component of Wnt3EGFP diffusion found in the BV. Moreover, HSPG may also assist in the transfer of Wnt bearing exosomes or lipoproteins by acting as their binding sites. A study demonstrated how HSPG guides the clearance of very low-density lipoprotein (VLDL) by forming a complex with Lrp (Wilsie and Orlando, 2003). Correspondingly, Eugster et al. explained how the interaction of the Drosophila lipoprotein with HSPG might influence the long-range signaling of Hedgehog in Drosophila (Eugster et al., 2007). On the same note, it was also determined how the functional activity of exosomes and vesicles is dependent on HSPG (Christianson and Belting, 2014). Further examination is required to confirm if HSPG aids the transport of Wnt3 packaged in exosomes or lipoprotein particles in the zebrafish brain. Nevertheless, our findings illustrate how HSPG moderates the long-range extracellular spreading, and by extension the function, of Wnt3 in the zebrafish brain.

It is also important to note that any modifications with fluorescent proteins are liable to have an influence on Wnt3 behavior. While we have previously shown that Wnt3EGFP is still biologically functional (Teh et al., 2015), EGFP could also change protein diffusion or transport. The relationship between the diffusion coefficient (D) of a molecule and its molecular weight (M) is :D1M3. Possible shape effects could potentially slow down the molecule even more. The mass of EGFP is ~27 kDa, and the mass of Wnt3 ~40 kDa. Hence, the measured diffusion coefficient of Wnt3EGFP is expected to be ~15% slower than the diffusion coefficient of Wnt3 molecule without the EGFP tag. However, this difference is relatively small and typically within the margins of the standard deviation of our measurements. As the standard deviation of our measurements includes measurement errors as well as the heterogeneity of the sample, we do not expect the label to have a strong influence. This is seen when comparing the diffusion of secEGFP and Wnt3EGFP, which show a difference of 30% in the diffusion coefficient as expected from their mass. Finally, as already discussed only Wnt3EGFP shows HSPG-dependent retardation in diffusion and Fzd1 binding. Therefore, we think that the influence on Wnt3 diffusion by the tag is within the normal variation of diffusion due to sample heterogeneity and is not influencing its interaction and function strongly.

Once Wnt ligands reach the target cells, the next question is how they interact with their target receptors. As we had established that it is highly unlikely for Wnts to diffuse in the interstitial spaces freely, they must be released from their chaperones or HSPG in order to interact with their receptors. One possible hand-off mechanism is the competitive binding of Wnts to their target receptors with a higher binding affinity (Naschberger et al., 2017; Wilson, 2017). Furthermore, the binding affinity of the Wnt-receptor complex also modulates their range and magnitude in vivo. Hence, we measured the in vivo binding affinity for Wnt3 with a potential target receptor, Fzd1 using quasi-PIE FCCS. We obtained an apparent Kd of 112 ± 15 nM in vivo, implying a strong interaction. However, the actual Kd might be even lower as the concentration of the endogenous proteins, and the photophysics of the fluorophore affects the estimated Kd (Foo et al., 2012). Nonetheless, it is an estimate of the native in vivo Wnt3-Fzd1 binding in their physiological condition, which is consistent with the results of in vitro experiments (Dijksterhuis et al., 2015). Interestingly, we also noticed that the interaction of Wnt3 with Fzd1 was dependent on the expression of the co-receptor Lrp5. We did not detect any cross-correlations when the expression of lrp5 was knocked down and the Dglobal for Wnt3EGFP increased by a factor ~3–5. From this result, it appears that Lrp5 is an essential component in facilitating the interaction of Wnt3 with Fzd1 with a significant influence on the diffusion coefficient and the long-range spreading of Wnt3. Hence, it is of interest to measure the Kd for Wnt3-LRP5 in the future and verify if the co-receptor is involved in the hand-off of Wnt from the carrier proteins and HSPG to its receptor. Note that Fzd1mApple expression in our transgenic line was driven by a 4 kb wnt3 promoter that mimicked the regular expression of Wnt3. While useful methodologically to measure auto- and juxtacrine interactions of Wnt3-Fzd1, additional work is needed in measuring the in vivo binding affinities for Wnt3 with Fzd receptors expressed under the control of their native promoters.

In conclusion, our results show the presence of distinct Wnt3 source and target regions in the developing zebrafish brain, and that Wnt3 is distributed from its source to target by extracellular diffusion. We observed that the diffusion of Wnt3 is retarded by a factor 3–5 due to tortuosity, a factor 5–6 due to receptor binding, and a factor ~2 due to HSPG, thus leading to a total reduction of a factor 30–60 when comparing Wnt3EGFP short-range (~28 µm2/s as measured by FCS) to long-range diffusion (~0.5 µm2/s. as measured by FRAP). This reconciles the diffusion coefficients derived from FCS and FRAP and indicates that the major part if not all the reduction seen for long-range compared to short-range diffusion of Wnt3 is explainable by tortuosity, receptor binding, and interactions with HSPG present in the interstitial spaces.

Finally, we demonstrated that the co-receptor Lrp5 drives the in vivo interaction of Wnt3 with Fzd1, and quantitatively determined their affinity. This demonstrates that the presence of proteins alone, be it signaling molecules or receptors, as determined by fluorescence microscopy does not report on the actual signaling but it is necessary to measure interactions or downstream signaling to differentiate the concentration from the functional distribution of signaling molecules. Overall, our findings provide a general outline of Wnt3 signaling in the zebrafish brain from expression and transport to target binding, which set a starting point for the quantitative investigation of the Wnt3 interaction network during zebrafish brain development.

Materials and methods

Key resources table.

Reagent type
(species) or resource
Designation Source or reference Identifiers Additional information
Gene (Danio rerio) fzd1 Ensembl Zebrafish (GRCZ11) ENSDART00000179533.2 Transcript: fzd1-201
Genetic reagent (Danio rerio) Tg(−4.0wnt3:Wnt3EGFP) Teh et al., 2015https://doi.org/10.1242/dev.127589 ZDB-TGCONSTRCT-150922–7 The transgenic zebrafish line expresses functional Wnt3EGFP driven by the 4 kb wnt3 promoter
Genetic reagent (Danio rerio) Tg(−4.0wnt3:EGFP) Teh et al., 2015https://doi.org/10.1242/dev.127589 ZDB-TGCONSTRCT-150922–8 The transgenic zebrafish line expresses cytosolic EGFP driven by the 4 kb wnt3 promoter
Genetic reagent (Danio rerio) Tg(−4.0wnt3:PLMTmApple)
[referred as Tg(−4.0wnt3:PMTmApple)
in this paper]

This paper ZDB-TGCONSTRCT-201104-1 Plasma membrane targeting sequence tagged with
 mApple (PMTmApple) in this transgenic line marks the plasma membrane of the Wnt3-producing cells(refer to "Generation of transgenic lines and zebrafish maintenance" for additional details).
Genetic reagent (Danio rerio) Tg(−4.0wnt3:Fzd1mApple) This paper ZDB-TGCONSTRCT-201104–2 The 4 kb wnt3 promoter drives Fzd1mApple expression in Wnt3-producing cells(refer to "Generation of transgenic lines and zebrafish maintenance" for additional details).
Genetic reagent (Danio rerio) Tg(−8.0cldnB:lynEGFP) Haas and Gilmour, 2006 2 https://doi.org/10.1016/j.devcel.2006.02.019 ZDB-TGCONSTRCT-070117–15
Genetic reagent (Danio rerio) Tg(7xTcf-Xla.Siam:NLS-mCherry) Moro et al., 2012 ZDB-TGCONSTRCT-110113–2 This construct uses seven TCF responsive elements fused to the Xenopus laevis siamois minimal promoter to drive expression of NLS-mCherry
Recombinant DNA reagent pminiTol2-4kbwnt3pro-PMTmApple This paper This plasmid is used to generate
Tg(−4.0wnt3:
PMTmApple) transgenic zebrafish(refer to "Generation of transgenic lines and zebrafish maintenance" for additional details).
Recombinant DNA reagent pminiTol2-4kb wnt3pro-Fzd1mApple This paper This plasmid is used to generate
Tg(−4.0wnt3:
Fzd1mApple) transgenic zebrafish(refer to "Generation of transgenic lines and zebrafish maintenance" for additional details).
Recombinant DNA reagent pminiTol2-4kbwnt3pro-secEGFP This paper This plasmid together with Tol2 transposase mRNA is microinjected into 1–2 cell stage zebrafish embryo for somatic expression of secGFP in Wnt3-positive domains (refer to "Generation of transgenic lines and zebrafish maintenance" for additional details).
Sequence-based reagent lrp5MoUp (Gene Tools) Willems et al., 2015 https://doi.org/10.1371/journal.pone.0131768 AGCTGCTCTTACAGTTTGTAGAGAG (25)
Sequence-based reagent lrp5MoDown (Gene Tools) CCTCCTTCATAGCTGCAAAAACAAG (25)
Sequence-based reagent mmlrp5 (Gene Tools) AGGTGCTGTTAGAGTTTCTAGACAG (25)
Chemical compound, drug Heparinase I from Flavobacterium heparinum Merck Cat# H2519
Chemical compound, drug Surfen Hydrate Merck Cat# S6951 A heparan sulfate antagonist
Software, algorithm Imaris Oxford Instruments RRID:SCR_007370 Check Materials and methods subsection Colocalization analysis

Fluorescence correlation spectroscopy

The molecular movement of fluorescently labeled molecules will cause fluorescence fluctuations during their entry and exit in a small open observation volume. These fluctuations contain the information about the dynamics of these molecules. In confocal FCS the confocal volume of the microscope setup defines the observation volume. The measured intensity trace is autocorrelated to extract the average concentrations and diffusion coefficients of the molecule in the sample. The autocorrelation function (ACF), G (τ), is given by

G(τ)=F(t)F(t+τ)F(t)F(t+τ) (1)

where F(t) is the fluorescence intensity at time t, τ is the lag time, and ⟨…⟩ represents the time average. For a Gaussian illumination profile, G(τ) for a three-dimensional free diffusion process with a single component and triplet state can be written as

G(τ)3D,1p,1t=1N(1+ττd)1[1+1K2(ττd)]12ftrip(τ)+G (2)

Here N is the mean number of molecules in the observation volume and is inversely proportional to the amplitude of the ACF G(0); τd is the diffusion time of the molecule; G is the convergence at long lag times; K is the structure factor that denotes the shape of the confocal volume

K=ωzωxy and Veff=π3/2ωxy2ωz (3)

where ωz and ωxy are the 1/e2 radii of the PSF in the axial and radial direction; and ftrip (τ) is the triplet function that accounts for the fraction of particles in the triplet state (Ftrip) with a triplet relaxation time of τtrip, and it is represented as

ftrip(τ)=1+Ftrip1Ftripeττtrip (4)

If two diffusing components are present, then the correlation function for two component 3D diffusion process G (τ)3D,2p,1t is

G(τ)3D,2p,1t=1N{(1F2)(1+ττd1)1[1+1K2(ττd1)]12+F2(1+ττd2)1[1+1K2(ττd2)]12}ftrip(τ)+G (5)

where F2 is the fraction of the second component. For a 2D diffusion process such as on a membrane, the fitting Equations (2) and (5) become

G(τ)2D,1p,1t=1N(1+ττd)1ftrip(τ)+G (6)
G(τ)2D,2p,1t=1N{(1F2)(1+ττd1)1+F2(1+ττd2)1}ftrip(τ)+G (7)

For FCS measurements, the system was first calibrated with Atto 488 dye for 488 nm and 485 nm laser lines and Atto 565 for 543 nm laser line. The known diffusion coefficient for the dye was 400 µm2/s at room temperature. The obtained correlation function was fit using Equation (2) and the free fit parameters were N, τ, τtrip, Ftrip, and G∞. The K value and Veff were calculated using Equation (3). The samples were dechorionated, anesthetized by Tricaine, and mounted in 1% low melt agarose in a No. 1.5 glass bottom MatTek petri dishes. The acquisition time for the measurements was 60 s and all measurements were performed at room temperature. For FCS measurements, we used fit models as determined by Bayes inference-based model selection (Sun et al., 2015). Bayes model selection aids in determining the most suitable model given the data and its noise. It corrects for highly correlated noise and model complexity and appropriately prevents overfitting. The most likely fit models for Wnt3EGFP, secEGFP, and LynEGFP in zebrafish embryos were determined in Sun et al., 2015. Accordingly, we used 2D-2particle-1triplet model (Equation 7) to fit for Wnt3EGFP, LynEGFP, and Fzd1mApple, and 2D-1particle-1triplet model (Equation 2) for secEGFP expressing embryos. The measurements in the BV were fit using 3D-2particle-1triplet model (Equation 5) for Wnt3EGFP and 3D-1particle-1triplet model (Equation 2) for secEGFP.

Quasi PIE fluorescence cross-correlation spectroscopy

FCCS is a valuable tool to study biomolecular interactions in live samples. When two interacting molecules tagged with spectrally different fluorophores transit through the observation volume, the intensity fluctuations from the two channels can be cross-correlated to obtain the cross-correlation function Gx (τ) given by:

Gx(τ)=Fg(t)Fr(t+τ)Fg(t)Fr(t) (8)

where Fg and Fr are the fluorescence intensity in the green and red channels, respectively.

For our FCCS measurements to detect Wnt3-Fzd1 interactions, we used an interleaved pulsed 485 nm laser line and a continuous wave 543 nm laser line to obtain the auto- and cross-correlation functions. This allowed us to apply statistical filtering (Kapusta et al., 2012) that helped in eliminating spectral cross-talk, background signal, and detector after-pulsing based on fluorescence lifetime correlation spectroscopy (FLCS) as detailed in Padilla-Parra et al., 2011. This is called quasi-PIE FCCS (Yavas et al., 2016).

Taking into account the background and spectral cross-talk, the amplitude of the ACF in the green channel GG(0), red channel GR(0), and the amplitude of the CCF Gx(0) can be written as:

GG(0)=(ηg,G)2Cg+(ηr,G)2Cr+(qgηg,G+qrηr,G)2CgrNAVeff[ηg,GCg+ηr,GCr+(qgηg,G+qrηr,G)Cgr+βGNAVeff]2 (9)
GR(0)=(ηg,R)2Cg+(ηr,R)2Cr+(qgηg,R+qrηr,R)2CgrNAVeff[ηg,RCg+ηr,RCr+(qgηg,G+qrηr,G)Cgr+βRNAVeff]2 (10)
Gx(0)=ηg,Rηg,GCg+ηr,Gηr,RCr+(qgηg,R+qrηr,R)2CgrNAVeff[ηg,RCg+ηr,RCr+(qgηg,G+qrηr,G)Cgr+βRNAVeff]2[ηg,RCg+ηr,RCr+(qgηg,G+qrηr,G)Cgr+βRNAVeff] (11)

Here ηg,G and ηr,R represent the mean counts per particle per second (cps) for EGFP in the green and mApple in the red channels, respectively. For our samples we obtained a ηg,G of ~1900 Hz and ηr,R of ~1400 Hz. βG and βR represent the count rates of background collected in the green and red channels, respectively. βR measured from blank WT embryo was ~400 Hz while FLCS correction eliminated the background in the green channel (βG=0). NA is the Avogadro’s number and Veff represents the effective confocal volume from calibration. ηr,G and ηg,R denote the cross-talk in the green and red channels, respectively, which was efficiently eliminated by quasi PIE FCCS (ηr,G and ηg,R=0). qg and qr are the correction factors due to FRET and quenching. Since the cps for Wnt3EFP and Fzd1mApple in their respective transgenics were same as that in double transgenic line, qg and qr were set to 1. Equations 9–11 were solved for Cg, Cr, and Cgr, which denote the concentration of the free green, free red, and bound molecules in the observation volume, respectively. Using Cg, Cr, and Cgr the dissociation constant (Kd) for the interaction which can be determined using Equation 12:

Kd=CgCrCgr (12)

Confocal microscope setup

An Olympus FV 1200 laser scanning confocal microscope (IX83; Olympus, Japan) integrated with a PicoQuant time resolved LSM upgrade kit (Microtime 200; GmbH, Germany) was used in this work. The sample was illuminated using a 488 nm laser beam (for EGFP) and 543 nm laser beam (for mApple) which was reflected to the back focal plane of an Olympus UPLSAPO 60X/1.2 NA water immersion objective. For all the experiments, the intensity of the laser before the objective was less than 20 µW. The emitted signal passes through a 120 µm pinhole before being filtered by an Olympus 510/23 emission filter (for EGFP) or an Olympus 605/55 emission filter (for mApple) and eventually directed to a PMT detector for imaging. For FCS measurements, 510/23 emission filter (Semrock, USA) and 615DF45 filter (Semrock, USA) were used, and the filtered emissions were recorded using a single photon sensitive avalanche photodiodes (SAPD) (SPCM-AQR-14; PerkinElmer). The recorded signal was then processed using SymPhoTime 64 (PicoQuant, Germany) to compute the autocorrelation function. For FCCS measurements, the sample was simultaneously illuminated with a pulsed 485 nm laser (LDH-D-C-488; PicoQuant) operated at 20 MHz repetition rate and a continuous 543 nm laser. The emission was separated using 560 DCLP dichroic mirror and directed to the 510/23 emission filter (Semrock, USA) and the 615DF45 filter (Semrock, USA). The signal recorded by SAPD was then analyzed by SymphoTime to generate the auto- and cross-correlations. The auto- and cross-correlation functions were fit with a custom written program on Igor Pro. Any brightness or contrast adjustments for the images were performed equally across all data.

Colocalization analysis

For the colocalization analysis of Wnt3EGFP and PMTmApple, confocal z-stacks of step size 0.5 µm were obtained with identical acquisition settings. An automatic threshold algorithm detailed in Zhu et al., 2016 was implemented to segment the data. The algorithm uses the correlation quotient to select an optimal threshold for segmentation as described in Li et al., 2004. Following the segmentation, the colocalization for each pixel was calculated based on ICA, the distance weight, and intensity weight (Li et al., 2004; Zhu et al., 2016). Finally, a pair of masks for the colocalized and non-colocalized pixels were generated. The colocalized pixels and non-colocalized pixels were used to construct 3D images of the source and target regions, respectively. The 3D images were built using ‘3D View’ module Imaris 9.5.0 (Oxford Instruments). The display setting was set to white background and the 3D reconstructed images are represented in ‘Normal Shading’ mode for improving contrast in Figures 2 and 3 and Videos 3 and 4.

Fluorescence recovery after photo bleaching

FRAP measurements were performed on an Olympus FV3000 laser scanning microscope. The mounted samples were imaged with a UPLSAPO 60X/1.2 NA water immersion objective (at 1.5× zoom) or a UPLSAPO 30X/1.05 NA silicone oil immersion objective (at 3× zoom). We used a 488 nm diode laser (for Wnt3EGFP and secEGFP) or a 561 nm diode laser (for PMTmApple) for our experiments. A DM 405/488/561/640 dichroic mirror separated the excitation and emission beams. The signal from the sample after passing through the dichroic mirror was filtered by a BP 510–550 emission band pass filter for the 488 nm laser beam, and by a BP 575–625 emission band pass filter for the 561 nm laser beam. The pinhole size was adjusted to 1 AU. For FRAP, five pre-bleach frames were obtained before irreversibly photo bleaching a circular region of interest (ROI) for 30 s. The fluorescence intensity recovery in the photobleached region was recorded for 30 min. The images were then analyzed using the FRAP module in the Olympus CellSens software. A reference region on the sample but outside the ROI was selected to correct for photo bleaching, and another reference region outside the sample was selected for background correction. The software then plotted an FRAP recovery curve for the ROI and fitted the FRAP curve with a double exponential fit to obtain the time constants for the fast (τfast) and the slow (τslow) component. The diffusion coefficient (Dglobal) was calculated using Equation 13 (Kang et al., 2015; Koppel et al., 1976), as described in the PicoQuan Practical Manual for Fluorescence Microsopy Techniques. However, it must be noted that this is an apparent estimate of the Dglobal as the distribution of fluorophores is not homogeneous, and we assume there is no diffusion during photo bleaching process.

Dglobal=r24τfast (13)

Generation of transgenic lines and zebrafish maintenance

To generate Tg(−4.0wnt3:PLMTmApple) [referred as Tg(−4.0wnt3:PMTmApple)] transgenic zebrafish, the 45 bp plasma membrane targeting-sequence (PMT) (ATGGGCTGCTTCTTCAGCAAGCGGCGGAAGGCCGACAAGGAGAGC) was cloned upstream and in-frame with mApple to generate PMTmApple open reading frame (ORF). The DNA fragment was subcloned into the 4-kbWnt3EGFP-miniTol2 recombinant plasmid (Teh et al., 2015) using Gibson assembly by replacing the Wnt3EGFP ORF with PMTmApple to give 4-kbPMT-mApple-miniTol2 recombinant plasmid.

To generate Tg(−4.0wnt3:Fzd1mApple), zebrafish fzd1 ORF (1617 bp; ENSDARG00000106062) was amplified by RT-PCR and subcloned into pGemTeasy. The Fzd1mApple DNA fragment was constructed by removing the Fzd1 stop codon and inserting in-frame (GGGS)two linker sequence (GGAGGAGGATCAGGAGGAGGATCA) tagged with mApple to Fzd1 C terminal by Gibson assembly. This DNA fragment was then subcloned into the 4-kbWnt3EGFP-miniTol2 recombinant plasmid using Gibson assembly by replacing the Wnt3EGFP ORF with Fzd1mApple to give 4-kbFzd1mApple-miniTol2 recombinant plasmid.

Stable wnt3 promoter-driven transgenic lines were generated as stated (Balciunas et al., 2006) by co-injection of transposase mRNA and 4-kbPMT-mApple-miniTol2 recombinant plasmid; co-injection of transposase mRNA and 4-kbFzd1mApple-miniTol2 recombinant plasmid, to generate Tg(−4.0wnt3:PMTmApple) and Tg(−4.0wnt3:Fzd1mApple) transgenic lines respectively.

For secEGFP measurements, embryos were injected with secEGFP mRNA (a gift from Prof. Karuna Sampath) at the 1–2 cell stage and subsequently screened for fluorescence. Additionally, secEGFP sequence was also subcloned into the 4-kbWnt3EGFP-miniTol2 recombinant plasmid by replacing Wnt3EGFP ORF with secEGFP to give 4-kbsecEGFP-miniTol2 recombinant plasmid which was co-injected with Tol2 transposase at 1–2 cell stage for 4 kb wnt3 promoter-driven somatic expression of secGFP. The embryos were subsequently screened before measurements.

Additional transgenic lines used are Tg(−8.0cldnB:lynEGFP) for in vivo imaging of membrane-tethered EGFP expression in the cerebellum (Haas and Gilmour, 2006) and Tg(−4.0wnt3:EGFP) for in vivo cytosolic EGFP expression in the domains of endogenous Wnt3 expression. Wnt3EGFP expression in the brain was imaged using Tg(−4.0wnt3:Wnt3EGFP)F2 (Teh et al., 2015). The Tg(7xTCF-Xla.Sia:NLS-mCherry) embryos were a gift from Tom Carney’s group.

Transgenic adult zebrafish and embryos were obtained from zebrafish facilities in the Institute of Molecular and Cell Biology (Singapore) and National University of Singapore. The Institutional Animal Care and Use Committee (IACUC) in Biological Resource Center (BRC), A*STAR, Singapore (IACUC #161105) and the National University of Singapore (IACUC# BR18-1023) have approved the entire study. Spawned transgenic embryos were staged as described (Kimmel et al., 1995). Embryos older than 30 hpf were treated with 1-phenyl-2-thiourea at 18 hpf to prevent formation of melanin.

Morpholino injection

The injected dose of lrp5 splice-blocking Morpholinos (MOs; Gene Tools, Corvalis, USA) lrp5MoUp (AGCTGCTCTTACAGTTTGTAGAGAG) targeting the Exon2-Intron2 splice junction and lrp5MoDown (CCTCCTTCATAGCTGCAAAAACAAG) targeting the Intron2-Exon3 splice junction were conducted in accordance to published research (Willems et al., 2015). As control, mismatch morpholino (mmlrp5) containing five nucleotide substitutions (AGgTGCTgTTAgAGTTTcTAGAcAG) was used (Willems et al., 2015).

Heparinase injection into the zebrafish BV and surfen treatment

Heparinase I from Flavobacterium heparinum (Merck) was dissolved in PBS to 1 U/μl and stored as frozen aliquots. For microinjection into the BV, MS-222 (Merck) anesthetized 48hpf zebrafish embryos were laterally mounted in 1% low gelling agarose (Merck). Reaction mix containing 0.1 U/μl heparinase I and 70,000 MW Dextran-Tetramethylrhodamine (ThermoFisher Scientific) was injected into the fourth ventricle of immobilized embryo. Injected embryos were freed from agarose and allowed to recover in glass bottomed dishes prior to imaging.

For surfen treatment, 24 hpf embryos were incubated in 3 µM surfen hydrate (Merck) in 1% DMSO in accordance with Naini et al., 2018 for 24 hr and measured at 48 hpf.

Sample selection, quantification, and statistics

Healthy embryos at their corresponding developmental stages were selected and screened for fluorescence. The embryos were then dechorionated, treated with Tricaine (3-amino benzoic acidethylester, Sigma), and mounted on a 35 mm 1.5 coverglass bottom dishes (MaTek, USA) for imaging and measurements. For FCS measurements, a maximum of 10 measurements were performed on a single embryo to reduce phototoxicity effects. No statistical tests were performed to predetermine sample size. A minimum for 15 measurements were analyzed for all FCS experiments using a minimum of four different embryos. All data are represented as mean ± SD. For comparing the effects of heparinase and surfen treatment on the dynamics of Wnt3EGFP, LynEGFP, and secEGFP with untreated embryos, larger sample sizes were used for more accuracy. The heparinase/surfen-treated and -untreated embryos were maintained at identical conditions. Unpaired two-sided t-test was performed to find the statistical significance between the diffusion coefficients of untreated- versus heparinase/surfen-treated embryos and p-values were considered statistically significant at p<0.05. All graphs were plotted and fitted on Igor Pro. For FRAP, only one measurement was performed on each embryo to reduce the phototoxicity effects. The embryos used for analysis in imaging, FCS, and FRAP measurements were from at least three different experiment sessions.

Acknowledgements

We thank the NUS Centre for BioImaging Sciences, SingaScope, and the Institute of Molecular and Cell Biology for providing microscope facility support and providing zebrafish care. TW acknowledges funding by the Singapore Ministry of Education (MOE2016-T3-1-005). SV is supported by a NUS Research Scholarship. We thank David Piston for providing the construct of mApple. We thank Tom Carney and Harsha Mahabaleshwar for providing the Tg(7xTcf:NLS-mCherry) wnt reporter line.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Thorsten Wohland, Email: twohland@nus.edu.sg.

Tanya T Whitfield, University of Sheffield, United Kingdom.

Marianne E Bronner, California Institute of Technology, United States.

Funding Information

This paper was supported by the following grant:

  • Ministry of Education - Singapore MOE2016-T3-1-005 to Thorsten Wohland, Paul T Matsudaira.

Additional information

Competing interests

No competing interests declared.

Author contributions

Conceptualization, Resources, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft.

Resources, Methodology, Writing - review and editing.

Resources, Software, Writing - review and editing.

Resources, Methodology.

Validation, Writing - review and editing.

Supervision, Funding acquisition, Writing - review and editing.

Conceptualization, Supervision, Funding acquisition, Validation, Project administration, Writing - review and editing.

Ethics

Animal experimentation: the study was performed in strict accordance with the Institutional Animal Care and Use Committee (IACUC) protocol of the Biological Resource Center (BRC), A*STAR, Singapore (IACUC #161105) and the National University of Singapore (IACUC# BR18-1023).

Additional files

Transparent reporting form

Data availability

All data analyzed during this study are included in the manuscript as source files. Source data files have been provided for Figures 4, 5, 6 and Table 1. Videos 1 and 2 represent the raw file used to construct Figures 2-3 and Videos 3-4, respectively.

References

  1. Anne SL, Govek EE, Ayrault O, Kim JH, Zhu X, Murphy DA, Van Aelst L, Roussel MF, Hatten ME. WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation. PLOS ONE. 2013;8:e81769. doi: 10.1371/journal.pone.0081769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Azbazdar Y, Ozalp O, Sezgin E, Veerapathiran S, Duncan AL, Sansom MSP, Eggeling C, Wohland T, Karaca E, Ozhan G. More favorable palmitic acid over palmitoleic acid modification of Wnt3 ensures its localization and activity in plasma membrane domains. Frontiers in Cell and Developmental Biology. 2019;7:7. doi: 10.3389/fcell.2019.00281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baeg GH, Lin X, Khare N, Baumgartner S, Perrimon N. Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of wingless. Development. 2001;128:87–94. doi: 10.1242/dev.128.1.87. [DOI] [PubMed] [Google Scholar]
  4. Baeg GH, Selva EM, Goodman RM, Dasgupta R, Perrimon N. The wingless morphogen gradient is established by the cooperative action of frizzled and heparan sulfate proteoglycan receptors. Developmental Biology. 2004;276:89–100. doi: 10.1016/j.ydbio.2004.08.023. [DOI] [PubMed] [Google Scholar]
  5. Balciunas D, Wangensteen KJ, Wilber A, Bell J, Geurts A, Sivasubbu S, Wang X, Hackett PB, Largaespada DA, McIvor RS, Ekker SC. Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLOS Genetics. 2006;2:e169. doi: 10.1371/journal.pgen.0020169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M, Niehrs C. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science. 2007;316:1619–1622. doi: 10.1126/science.1137065. [DOI] [PubMed] [Google Scholar]
  7. Bulfone A, Puelles L, Porteus MH, Frohman MA, Martin GR, Rubenstein JL. Spatially restricted expression of Dlx-1, Dlx-2 (Tes-1), Gbx-2, and Wnt-3 in the embryonic day 12.5 mouse forebrain defines potential transverse and longitudinal segmental boundaries. The Journal of Neuroscience. 1993;13:3155–3172. doi: 10.1523/JNEUROSCI.13-07-03155.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Callejo A, Bilioni A, Mollica E, Gorfinkiel N, Andrés G, Ibáñez C, Torroja C, Doglio L, Sierra J, Guerrero I. Dispatched mediates hedgehog basolateral release to form the long-range morphogenetic gradient in the Drosophila wing disk epithelium. PNAS. 2011;108:12591–12598. doi: 10.1073/pnas.1106881108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chizhikov VV, Lindgren AG, Currle DS, Rose MF, Monuki ES, Millen KJ. The roof plate regulates cerebellar cell-type specification and proliferation. Development. 2006;133:2793–2804. doi: 10.1242/dev.02441. [DOI] [PubMed] [Google Scholar]
  10. Chizhikov VV, Millen KJ. Roof plate-dependent patterning of the vertebrate dorsal central nervous system. Developmental Biology. 2005;277:287–295. doi: 10.1016/j.ydbio.2004.10.011. [DOI] [PubMed] [Google Scholar]
  11. Christianson HC, Belting M. Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biology. 2014;35:51–55. doi: 10.1016/j.matbio.2013.10.004. [DOI] [PubMed] [Google Scholar]
  12. Chu ML, Ahn VE, Choi HJ, Daniels DL, Nusse R, Weis WI. Structural studies of wnts and identification of an LRP6 binding site. Structure. 2013;21:1235–1242. doi: 10.1016/j.str.2013.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Clements WK, Ong KG, Traver D. Zebrafish wnt3 is expressed in developing neural tissue. Developmental Dynamics. 2009;238:1788–1795. doi: 10.1002/dvdy.21977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149:1192–1205. doi: 10.1016/j.cell.2012.05.012. [DOI] [PubMed] [Google Scholar]
  15. Coudreuse D, Korswagen HC. The making of wnt: new insights into wnt maturation, sorting and secretion. Development. 2007;134:3–12. doi: 10.1242/dev.02699. [DOI] [PubMed] [Google Scholar]
  16. Dijksterhuis JP, Baljinnyam B, Stanger K, Sercan HO, Ji Y, Andres O, Rubin JS, Hannoush RN, Schulte G. Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs. Journal of Biological Chemistry. 2015;290:6789–6798. doi: 10.1074/jbc.M114.612648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Duncan RN, Panahi S, Piotrowski T, Dorsky RI. Identification of wnt genes expressed in neural progenitor zones during zebrafish brain development. PLOS ONE. 2015;10:e0145810. doi: 10.1371/journal.pone.0145810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Enderlein J, Gregor I, Patra D, Dertinger T, Kaupp UB. Performance of fluorescence correlation spectroscopy for measuring diffusion and concentration. ChemPhysChem. 2005;6:2324–2336. doi: 10.1002/cphc.200500414. [DOI] [PubMed] [Google Scholar]
  19. Esteve P, Sandonìs A, Ibañez C, Shimono A, Guerrero I, Bovolenta P. Secreted frizzled-related proteins are required for wnt/β-catenin signalling activation in the vertebrate optic cup. Development. 2011;138:4179–4184. doi: 10.1242/dev.065839. [DOI] [PubMed] [Google Scholar]
  20. Eugster C, Panáková D, Mahmoud A, Eaton S. Lipoprotein-heparan sulfate interactions in the hh pathway. Developmental Cell. 2007;13:57–71. doi: 10.1016/j.devcel.2007.04.019. [DOI] [PubMed] [Google Scholar]
  21. Foo YH, Naredi-Rainer N, Lamb DC, Ahmed S, Wohland T. Factors affecting the quantification of biomolecular interactions by fluorescence cross-correlation spectroscopy. Biophysical Journal. 2012;102:1174–1183. doi: 10.1016/j.bpj.2012.01.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Fuerer C, Habib SJ, Nusse R. A study on the interactions between heparan sulfate proteoglycans and wnt proteins. Developmental Dynamics. 2010;239:184–190. doi: 10.1002/dvdy.22067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Galli LM, Barnes TL, Secrest SS, Kadowaki T, Burrus LW. Porcupine-mediated lipid-modification regulates the activity and distribution of wnt proteins in the chick neural tube. Development. 2007;134:3339–3348. doi: 10.1242/dev.02881. [DOI] [PubMed] [Google Scholar]
  24. Garriock RJ, Warkman AS, Meadows SM, D'Agostino S, Krieg PA. Census of vertebrate wnt genes: isolation and developmental expression of Xenopus Wnt2, Wnt3, Wnt9a, Wnt9b, Wnt10a, and Wnt16. Developmental Dynamics. 2007;236:1249–1258. doi: 10.1002/dvdy.21156. [DOI] [PubMed] [Google Scholar]
  25. Gibbs HC, Chang-Gonzalez A, Hwang W, Yeh AT, Lekven AC. Midbrain-Hindbrain boundary morphogenesis: at the intersection of wnt and fgf signaling. Frontiers in Neuroanatomy. 2017;11:1–17. doi: 10.3389/fnana.2017.00064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Greco V, Hannus M, Eaton S. Argosomes: a potential vehicle for the spread of morphogens through epithelia. Cell. 2001;106:633–645. doi: 10.1016/s0092-8674(01)00484-6. [DOI] [PubMed] [Google Scholar]
  27. Haas P, Gilmour D. Chemokine signaling mediates self-organizing tissue migration in the zebrafish lateral line. Developmental Cell. 2006;10:673–680. doi: 10.1016/j.devcel.2006.02.019. [DOI] [PubMed] [Google Scholar]
  28. Han C, Yan D, Belenkaya TY, Lin X. Drosophila glypicans dally and Dally-like shape the extracellular wingless morphogen gradient in the wing disc. Development. 2005;132:667–679. doi: 10.1242/dev.01636. [DOI] [PubMed] [Google Scholar]
  29. Herr P, Basler K. Porcupine-mediated lipidation is required for wnt recognition by wls. Developmental Biology. 2012;361:392–402. doi: 10.1016/j.ydbio.2011.11.003. [DOI] [PubMed] [Google Scholar]
  30. Hikasa H, Sokol SY. Wnt signaling in vertebrate Axis specification. Cold Spring Harbor Perspectives in Biology. 2013;5:a007955. doi: 10.1101/cshperspect.a007955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hirai H, Matoba K, Mihara E, Arimori T, Takagi J. Crystal structure of a mammalian Wnt-frizzled complex. Nature Structural & Molecular Biology. 2019;26:372–379. doi: 10.1038/s41594-019-0216-z. [DOI] [PubMed] [Google Scholar]
  32. Holzer T, Liffers K, Rahm K, Trageser B, Ozbek S, Gradl D. Live imaging of active fluorophore labelled wnt proteins. FEBS Letters. 2012;586:1638–1644. doi: 10.1016/j.febslet.2012.04.035. [DOI] [PubMed] [Google Scholar]
  33. Hsieh JC, Rattner A, Smallwood PM, Nathans J. Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate wnt protein. PNAS. 1999;96:3546–3551. doi: 10.1073/pnas.96.7.3546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Huang H, Kornberg TB. Myoblast cytonemes mediate wg signaling from the wing imaginal disc and Delta-Notch signaling to the air sac primordium. eLife. 2015;4:e06114. doi: 10.7554/eLife.06114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC. Structural basis of wnt. Science. 2012;337:59–64. doi: 10.1126/science.1222879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Jessell TM. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nature Reviews Genetics. 2000;1:20–29. doi: 10.1038/35049541. [DOI] [PubMed] [Google Scholar]
  37. Kaiser K, Gyllborg D, Procházka J, Salašová A, Kompaníková P, Molina FL, Laguna-Goya R, Radaszkiewicz T, Harnoš J, Procházková M, Potěšil D, Barker RA, Casado AG, Zdráhal Z, Sedláček R, Arenas E, Villaescusa JC, Bryja V. WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis. Nature Communications. 2019;10:1–15. doi: 10.1038/s41467-019-09298-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kang M, Cordova M, Chen CSJ, Rajadhyaksha M. Simplified equation to extract diffusion coefficients from confocal FRAP data. Journal of Investigative Dermatology. 2015;135:612–615. doi: 10.1111/tra.12008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kapusta P, Macháň R, Benda A, Hof M. Fluorescence lifetime correlation spectroscopy (FLCS): concepts, applications and outlook. International Journal of Molecular Sciences. 2012;13:12890–12910. doi: 10.3390/ijms131012890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kim SA, Heinze KG, Schwille P. Fluorescence correlation spectroscopy in living cells. Nature Methods. 2007;4:963–973. doi: 10.1038/nmeth1104. [DOI] [PubMed] [Google Scholar]
  41. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Developmental Dynamics. 1995;203:253–310. doi: 10.1002/aja.1002030302. [DOI] [PubMed] [Google Scholar]
  42. Kirkpatrick CA, Selleck SB. Heparan sulfate proteoglycans at a glance. Journal of Cell Science. 2007;120:1829–1832. doi: 10.1242/jcs.03432. [DOI] [PubMed] [Google Scholar]
  43. Klonis N, Rug M, Harper I, Wickham M, Cowman A, Tilley L. Fluorescence photobleaching analysis for the study of cellular dynamics. European Biophysics Journal. 2002;31:36–51. doi: 10.1007/s00249-001-0202-2. [DOI] [PubMed] [Google Scholar]
  44. Kondrychyn I, Teh C, Sin M, Korzh V. Stretching morphogenesis of the roof plate and formation of the central canal. PLOS ONE. 2013;8:e56219. doi: 10.1371/journal.pone.0056219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Koppel DE, Axelrod D, Schlessinger J, Elson EL, Webb WW. Dynamics of fluorescence marker concentration as a probe of mobility. Biophysical Journal. 1976;16:1315–1329. doi: 10.1016/S0006-3495(76)85776-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Krichevsky O, Bonnet G. Fluorescence correlation spectroscopy: the technique and its applications. Reports on Progress in Physics. 2002;65:251–297. doi: 10.1088/0034-4885/65/2/203. [DOI] [Google Scholar]
  47. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, Stanley EF. A syntaxin 1, galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. Journal of Neuroscience. 2004;24:4070–4081. doi: 10.1523/JNEUROSCI.0346-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Lipinski C, Hopkins A. Navigating chemical space for biology and medicine. Nature. 2004;432:855–861. doi: 10.1038/nature03193. [DOI] [PubMed] [Google Scholar]
  49. Liu P, Wakamiya M, Shea MJ, Albrecht U, Behringer RR, Bradley A. Requirement for Wnt3 in vertebrate Axis formation. Nature Genetics. 1999;22:361–365. doi: 10.1038/11932. [DOI] [PubMed] [Google Scholar]
  50. Logan CY, Nusse R. The wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology. 2004;20:781–810. doi: 10.1146/annurev.cellbio.20.010403.113126. [DOI] [PubMed] [Google Scholar]
  51. Lord ND, Carte AN, Abitua PB, Schier AF. The pattern of nodal morphogen signaling is shaped by co-receptor expression. bioRxiv. 2019 doi: 10.1101/2019.12.30.891101. [DOI] [PMC free article] [PubMed]
  52. Macháň R, Foo YH, Wohland T. On the equivalence of FCS and FRAP: simultaneous lipid membrane measurements. Biophysical Journal. 2016;111:152–161. doi: 10.1016/j.bpj.2016.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Magde D, Elson EL, Webb WW. Fluorescence correlation spectroscopy. II. an experimental realization. Biopolymers. 1974;13:29–61. doi: 10.1002/bip.1974.360130103. [DOI] [PubMed] [Google Scholar]
  54. Mattes B, Dang Y, Greicius G, Kaufmann LT, Prunsche B, Rosenbauer J, Stegmaier J, Mikut R, Özbek S, Nienhaus GU, Schug A, Virshup DM, Scholpp S. Wnt/PCP controls spreading of wnt/β-catenin signals by cytonemes in vertebrates. eLife. 2018;7:e36953. doi: 10.7554/eLife.36953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. McGough IJ, Vecchia L, Bishop B, Malinauskas T, Beckett K, Joshi D, O'Reilly N, Siebold C, Jones EY, Vincent JP. Glypicans shield the wnt lipid moiety to enable signalling at a distance. Nature. 2020;585:85–90. doi: 10.1038/s41586-020-2498-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Mihara E, Hirai H, Yamamoto H, Tamura-Kawakami K, Matano M, Kikuchi A, Sato T, Takagi J. Active and water-soluble form of lipidated wnt protein is maintained by a serum glycoprotein afamin/α-albumin. eLife. 2016;5:e11621. doi: 10.7554/eLife.11621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Mii Y, Yamamoto T, Takada R, Mizumoto S, Matsuyama M, Yamada S, Takada S, Taira M. Roles of two types of heparan sulfate clusters in wnt distribution and signaling in Xenopus. Nature Communications. 2017;8:1–19. doi: 10.1038/s41467-017-02076-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Mii Y, Taira M. Secreted Frizzled-related proteins enhance the diffusion of wnt ligands and expand their signalling range. Development. 2009;136:4083–4088. doi: 10.1242/dev.032524. [DOI] [PubMed] [Google Scholar]
  59. Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene. 2006;25:7461–7468. doi: 10.1038/sj.onc.1210053. [DOI] [PubMed] [Google Scholar]
  60. Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of wnt signaling through beta-catenin. Science. 2002;296:1644–1646. doi: 10.1126/science.1071549. [DOI] [PubMed] [Google Scholar]
  61. Moro E, Ozhan-Kizil G, Mongera A, Beis D, Wierzbicki C, Young RM, Bournele D, Domenichini A, Valdivia LE, Lum L, Chen C, Amatruda JF, Tiso N, Weidinger G, Argenton F. In vivo wnt signaling tracing through a transgenic biosensor fish reveals novel activity domains. Developmental Biology. 2012;366:327–340. doi: 10.1016/j.ydbio.2012.03.023. [DOI] [PubMed] [Google Scholar]
  62. Müller P, Rogers KW, Jordan BM, Lee JS, Robson D, Ramanathan S, Schier AF. Differential diffusivity of nodal and lefty underlies a reaction-diffusion patterning system. Science. 2012;336:721–724. doi: 10.1126/science.1221920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Müller P, Rogers KW, Yu SR, Brand M, Schier AF. Morphogen transport. Development. 2013;140:1621–1638. doi: 10.1242/dev.083519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Mulligan KA, Fuerer C, Ching W, Fish M, Willert K, Nusse R. Secreted Wingless-interacting molecule (Swim) promotes long-range signaling by maintaining wingless solubility. PNAS. 2012;109:370–377. doi: 10.1073/pnas.1119197109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Naini SMA, Yanicostas C, Hassan-Abdi R, Blondeel S, Bennis M, Weiss RJ, Tor Y, Esko JD, Soussi-Yanicostas N. Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy. Translational Neurodegeneration. 2018;7:1–9. doi: 10.1186/s40035-018-0111-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Naschberger A, Orry A, Lechner S, Bowler MW, Nurizzo D, Novokmet M, Keller MA, Oemer G, Seppi D, Haslbeck M, Pansi K, Dieplinger H, Rupp B. Structural evidence for a role of the Multi-functional human glycoprotein afamin in wnt transport. Structure. 2017;25:1907–1915. doi: 10.1016/j.str.2017.10.006. [DOI] [PubMed] [Google Scholar]
  67. Neumann S, Coudreuse DY, van der Westhuyzen DR, Eckhardt ER, Korswagen HC, Schmitz G, Sprong H. Mammalian Wnt3a is released on lipoprotein particles. Traffic. 2009;10:334–343. doi: 10.1111/j.1600-0854.2008.00872.x. [DOI] [PubMed] [Google Scholar]
  68. Ng XW, Teh C, Korzh V, Wohland T. The secreted signaling protein Wnt3 is associated with membrane domains in vivo: a SPIM-FCS study. Biophysical Journal. 2016;111:418–429. doi: 10.1016/j.bpj.2016.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Niehrs C. The complex world of WNT receptor signalling. Nature Reviews Molecular Cell Biology. 2012;13:767–779. doi: 10.1038/nrm3470. [DOI] [PubMed] [Google Scholar]
  70. Ohkawara B, Yamamoto TS, Tada M, Ueno N. Role of glypican 4 in the regulation of convergent extension movements during gastrulation in Xenopus laevis. Development. 2003;130:2129–2138. doi: 10.1242/dev.00435. [DOI] [PubMed] [Google Scholar]
  71. Padilla-Parra S, Audugé N, Coppey-Moisan M, Tramier M. Dual-color fluorescence lifetime correlation spectroscopy to quantify protein-protein interactions in live cell. Microscopy Research and Technique. 2011;74:788–793. doi: 10.1002/jemt.21015. [DOI] [PubMed] [Google Scholar]
  72. Panáková D, Sprong H, Marois E, Thiele C, Eaton S. Lipoprotein particles are required for hedgehog and wingless signalling. Nature. 2005;435:58–65. doi: 10.1038/nature03504. [DOI] [PubMed] [Google Scholar]
  73. Raible F, Brand M. Divide et impera--the midbrain-hindbrain boundary and its organizer. Trends in Neurosciences. 2004;27:727–734. doi: 10.1016/j.tins.2004.10.003. [DOI] [PubMed] [Google Scholar]
  74. Ries J, Yu SR, Burkhardt M, Brand M, Schwille P. Modular scanning FCS quantifies receptor-ligand interactions in living multicellular organisms. Nature Methods. 2009;6:643–645. doi: 10.1038/nmeth.1355. [DOI] [PubMed] [Google Scholar]
  75. Routledge D, Scholpp S. Mechanisms of intercellular wnt transport. Development. 2019;146:dev176073. doi: 10.1242/dev.176073. [DOI] [PubMed] [Google Scholar]
  76. Saied-Santiago K, Townley RA, Attonito JD, Cunha DSda, Díaz-Balzac CA, Tecl E, Bülow HE. Coordination of heparan sulfate proteoglycans with wnt signaling to control cellular migrations. Genetics. 2017;206:1699–1725. doi: 10.1534/genetics.115.185116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Schubert M, Holland LZ. The Wnt Gene Family and the Evolutionary Conservation of Wnt Expression. Madame Curie Bioscience Database; 2013. [Google Scholar]
  78. Schulte G, Wright SC. Frizzleds as GPCRs - More conventional than we thought! Trends in Pharmacological Sciences. 2018;39:828–842. doi: 10.1016/j.tips.2018.07.001. [DOI] [PubMed] [Google Scholar]
  79. Schwille P, Meyer-Almes FJ, Rigler R. Dual-color fluorescence cross-correlation spectroscopy for multicomponent diffusional analysis in solution. Biophysical Journal. 1997;72:1878–1886. doi: 10.1016/S0006-3495(97)78833-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Sezgin E, Azbazdar Y, Ng XW, Teh C, Simons K, Weidinger G, Wohland T, Eggeling C, Ozhan G. Binding of canonical wnt ligands to their receptor complexes occurs in ordered plasma membrane environments. The FEBS Journal. 2017;284:2513–2526. doi: 10.1111/febs.14139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Shi X, Foo YH, Sudhaharan T, Chong SW, Korzh V, Ahmed S, Wohland T. Determination of dissociation constants in living zebrafish embryos with single wavelength fluorescence cross-correlation spectroscopy. Biophysical Journal. 2009;97:678–686. doi: 10.1016/j.bpj.2009.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Speer KF, Sommer A, Tajer B, Mullins MC, Klein PS, Lemmon MA. Non-acylated wnts can promote signaling. Cell Reports. 2019;26:875–883. doi: 10.1016/j.celrep.2018.12.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Stanganello E, Hagemann AIH, Mattes B, Sinner C, Meyen D, Weber S, Schug A, Raz E, Scholpp S. Filopodia-based wnt transport during vertebrate tissue patterning. Nature Communications. 2015;6:1–14. doi: 10.1038/ncomms6846. [DOI] [PubMed] [Google Scholar]
  84. Sudhaharan T, Liu P, Foo YH, Bu W, Lim KB, Wohland T, Ahmed S. Determination of in vivo dissociation constant, KD, of Cdc42-effector complexes in live mammalian cells using single wavelength fluorescence cross-correlation spectroscopy. Journal of Biological Chemistry. 2009;284:13602–13609. doi: 10.1074/jbc.A900894200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Sun G, Guo SM, Teh C, Korzh V, Bathe M, Wohland T. Bayesian model selection applied to the analysis of fluorescence correlation spectroscopy data of fluorescent proteins in vitro and in vivo. Analytical Chemistry. 2015;87:4326–4333. doi: 10.1021/acs.analchem.5b00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Tao Q, Yokota C, Puck H, Kofron M, Birsoy B, Yan D, Asashima M, Wylie CC, Lin X, Heasman J. Maternal wnt11 activates the canonical wnt signaling pathway required for Axis formation in Xenopus embryos. Cell. 2005;120:857–871. doi: 10.1016/j.cell.2005.01.013. [DOI] [PubMed] [Google Scholar]
  87. Teh C, Sun G, Shen H, Korzh V, Wohland T. Modulating the expression level of secreted Wnt3 influences cerebellum development in zebrafish transgenics. Development. 2015;142:3721–3733. doi: 10.1242/dev.127589. [DOI] [PubMed] [Google Scholar]
  88. Topczewski J, Sepich DS, Myers DC, Walker C, Amores A, Lele Z, Hammerschmidt M, Postlethwait J, Solnica-Krezel L. The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension. Developmental Cell. 2001;1:251–264. doi: 10.1016/S1534-5807(01)00005-3. [DOI] [PubMed] [Google Scholar]
  89. Wang Y, Wang X, Wohland T, Sampath K. Extracellular interactions and ligand degradation shape the nodal morphogen gradient. eLife. 2016;5:e13879. doi: 10.7554/eLife.13879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Willems B, Tao S, Yu T, Huysseune A, Witten PE, Winkler C. The wnt Co-Receptor Lrp5 is required for cranial neural crest cell migration in zebrafish. PLOS ONE. 2015;10:e0131768. doi: 10.1371/journal.pone.0131768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Wilsie LC, Orlando RA. The low density lipoprotein Receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate Proteoglycan-mediated lipoprotein catabolism. Journal of Biological Chemistry. 2003;278:15758–15764. doi: 10.1074/jbc.M208786200. [DOI] [PubMed] [Google Scholar]
  92. Wilson MA. Structural insight into a Fatty-Acyl chaperone for wnt proteins. Structure. 2017;25:1781–1782. doi: 10.1016/j.str.2017.11.009. [DOI] [PubMed] [Google Scholar]
  93. Wu CH, Nusse R. Ligand receptor interactions in the wnt signaling pathway in Drosophila. Journal of Biological Chemistry. 2002;277:41762–41769. doi: 10.1074/jbc.M207850200. [DOI] [PubMed] [Google Scholar]
  94. Wurst W, Bally-Cuif L. Neural plate patterning: upstream and downstream of the isthmic organizer. Nature Reviews Neuroscience. 2001;2:99–108. doi: 10.1038/35053516. [DOI] [PubMed] [Google Scholar]
  95. Yan D, Lin X. Shaping morphogen gradients by proteoglycans. Cold Spring Harbor Perspectives in Biology. 2009;1:a002493. doi: 10.1101/cshperspect.a002493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Yavas S, Macháň R, Wohland T. The epidermal growth factor receptor forms Location-Dependent complexes in resting cells. Biophysical Journal. 2016;111:2241–2254. doi: 10.1016/j.bpj.2016.09.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Yu SR, Burkhardt M, Nowak M, Ries J, Petrásek Z, Scholpp S, Schwille P, Brand M. Fgf8 morphogen gradient forms by a source-sink mechanism with freely diffusing molecules. Nature. 2009;461:533–536. doi: 10.1038/nature08391. [DOI] [PubMed] [Google Scholar]
  98. Zhu S, Welsch RE, Matsudaira PT. A method to quantify co-localization in biological images. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2016. [DOI] [PubMed] [Google Scholar]

Decision letter

Editor: Tanya T Whitfield1

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

The movement of morphogen ligands through tissue in vivo is an important and understudied topic. In this study, Veerapathiran et al. examine the sources and distribution mechanism of a morphogen protein, Wnt3, in the developing zebrafish brain. Using a fluorescent Wnt3 fusion protein under the control of Wnt3 regulatory sequences, the authors show that Wnt3 spreads a considerable distance from the cells that produce it, as marked by a membrane-bound fluorescent protein whose production is controlled by the same regulatory elements. The authors also use biophysical methods to characterise the diffusion and mobility of the Wnt fusion protein and to investigate the interaction between Wnt3 and its receptor, Fzd1. This is a high quality study that nicely demonstrates the long range dispersion of Wnt3, and sheds light on the underlying mechanism.

Decision letter after peer review:

Thank you for submitting your article "Wnt3 distribution in the zebrafish brain is determined by expression, diffusion and multiple molecular interactions" for consideration by eLife. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is "in revision at eLife". Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)

In this study, Veerapthiran et al. examine the sources and spatial distribution of Wnt3 protein in the Zebrafish brain at 24-48hpf using a Wnt-EGFP fusion protein. They also use biophysical methods to characterize the diffusion and mobility of the Wnt fusion and to investigate the interaction between Wnt3 and Frz1. The movement of morphogen ligands through tissue in vivo is an important and understudied topic. This study has the advantage of looking in vivo at proteins expressed at near endogenous levels (the Wnt3 transgene is expressed using the Wnt3 promoter region).

While the reviewers all agreed that the study has potential, they have also identified quite a substantial number of revisions that must be addressed to have confidence in the results and for this study to be of broad interest. Some similar points have come up in all three reviews, which are appended in full below for your information.

Reviewer #1:

1) I am concerned about the comparisons between the source and distribution of Wnt3 using different transgenes with different fluorescent proteins. The data are also presented non-quantitatively so that it is difficult to tell whether, for example, there is mApple fluorescence above background (for source cells) outside of the limited regions described in results. The authors should address: (a) the distribution of Wnt3 mRNA by in situ at 24h (Figure 2—figure supplement 1) appears significantly broader than mApple fluorescence at 24h (b) the source appears to expand considerably from 24 to 48h in mApple fluorescence but there is no corresponding expansion in the Wnt3 mRNA (c) the number of target cells seem to reduce during this time the source is expanding. Data quantifying the distribution of the two fluorescent proteins throughout the region of interest should be shown. It would also be helpful to show in situ data for EGFP so one could compare the source to the target using a single transgene.

2) The authors should better explain the process of model selection. The text simply says that "Bayesian model selection" is applied without explaining further. The authors should explain how their data justify using a 2-component (fast and slow) model, how much is the fit improved by using 2 components compared to 1 component and by including a triplet state? Given the relatively large number of parameters, how do the authors ensure that they avoid overfitting their data? In this regard, it would be helpful for the authors to subject their controls to the analysis with the same model. For example, if secGFP is analyzed with this model, does it yield Ftrip ~ 0 and Fslow ~ 0?

3) There isn't sufficient explanation of the biology that the authors believe is behind their measurements. Is the authors' interpretation of the slow fraction that it is bound to the membrane? It is surprising that the slow fraction of Wnt does not differ from that of Lyn which is not secreted? Could this also be Wnt bound to the matrix (e.g. HSPG)? Why does heperanse treatment affect the fast diffusion rate but nothing else? This is supposedly the diffusion of free Wnt. If it is merely clearing more extracellular space, shouldn't the diffusion of secGFP be affected as well? If it is unbinding Wnts from heparin, it would seem that this would be better described by treating bound and unbound Wnts separately.

4) For the measurement of binding affinity, a number is given but the controls are not sufficiently quantitative to give confidence in this number. The best would be to use the same method to calculate a known binding affinity. In the absence of this, is the "binding affinity" computed for the positive control substantially higher than that for Wnt-Frz? In any case, can the authors use this method to spatially map Wnt-Frz interactions in the embryo? This would be more interesting than extracting a binding constant. The authors mention that no binding was detected in the ventral cerebellum or optic tectum but no data is provided.

Reviewer #2:

The authors aim to identify and characterise the expression and mobility of Wnt3 ligands within the developing dorsal midbrain of the zebrafish embryo. To do so, the authors use a previously generated transgenic zebrafish line with fluorescently tagged Wnt3GFP and Fz1mApple under the endogenous Wnt3 promoter Tg(-4.0wnt3:) (The et al., 2015). Using these transgenic lines coupled with other fluorescent probes such as secEGFP, LynEGFP and PMTmApple (membrane-tethered EGFP/mApple) under the same regulatory elements, the authors observed that Wnt3GFP is mobilised from the source regions (roof plate of tectum, midbrain-hindbrain boundary, and dorsal cerebellum) to the distal areas around the tectum and cerebellum. The authors then explored the mode of transport by utilising FCS and FRAP technology. FCS analysis suggested that two components of Wnt3GFP were either fast or slow diffusing. Upon further investigation using the heparin sulphate proteoglycan inhibitor, heparinase, it was observed that the fast component of Wnt3GFP was increased. Still, the slow one was unchanged, suggesting that Wnt3GFP is transported extracellularly with the help of HSPGs.

Furthermore, FRAP measurements confirmed this and proved that the recovery of Wnt3GFP was not as a result of cellular protein renewal. Lastly, the authors quantified the interaction between Wnt3GFP and target cell surface receptor Fzd1mApple. This interaction was consistent with in vitro quantification but at a higher dissociation constant, Kd. Finally, the data suggest an importance of co-receptor Lrp5 and identified that Wnt3GFP-Fz1mApple interaction is strongly dependent on Lrp5 expression.

There are two main points of criticism. Firstly, the authors need to demonstrate the bioactivity of Wnt3GFP in the system. This is very important because it is unclear to which extend Wnt3GFP fulfils the function of Wnt3 during development in comparison to the endogenous Wnt3. Furthermore, the authors need to be more explicit in the text that they describe the characteristics of Wnt3GFP and Fzd1mApple – and not the endogenous protein. This needs to be amended at many places in the text/figure legends etc. if appropriate

Secondly, the studies using FCCS to determine the Kd between Wnt3GFP and Fzd1mApple with/without Lrp5 in vivo is a highlight of the paper. I would suggest interfering with Fzd1, Wnt3 and Lrp5 function to demonstrate similar requirements for these three components in midbrain development. Although some publications are suggesting a role in midbrain development for these components, functional validation of the FCCS experiments would significantly strengthen the second core message of the manuscript.

Conclusion: Overall, this paper adopts a robust approach to investigating the in vivo dynamics of Wnt3GFP in the developing zebrafish brain. This paper delivers novel data with little evident criticism of the experimental approach and conclusions drawn.

Reviewer #3:

This paper focuses on the mechanism whereby Wnt3 is distributed from the producing cells in the developing zebrafish brain. The authors use a Wnt3EFGP fusion protein under the control of Wnt3 regulatory sequences, and show that it spreads considerably away from the producing cells, as marked by a membrane-bound TmApple fluorescent protein whose production is controlled by the same regulatory elements. They use FCS and FRAP to obtain diffusion coefficients, and demonstrate that HSPGs restrain the mobility of Wnt3. They go on to calculate the binding affinity for the frizzled receptor (Fzd1) and show that Wnt3's ability to bind Fzd1 requires Lrp5.

I think that this is a nice study and for the most part the work is well done. I do think though that in order to interpret the data correctly, considerably more controls are needed. There are also some other missing experiments that would strengthen the findings of the study.

1) The first issue concerns the use of the 4 kb upstream region of Wnt3 to control expression of the Wnt3EGFP and the PMTmApple. The authors say that it is a faithful reporter of Wnt3 expression, yet the wholemount in situs shown show a much wider distribution then the PMTmApple would suggest. This made me wonder whether the expression of the Wnt3EGFP and PMTmApple is actually wider than the authors assume, which would confound the results as it could be that the Wnt3EGFP is not as mobile as they think. To control for this, it is important to perform an EGFP in situ to prove that the source of Wnt3EGFP really is localized.

2) The second issue concerns the possibility that free EGFP could be produced by cleavage of the Wnt3EGFP. If this was occurring, then it could contribute to the fast diffusing species measured. The authors must be able to rule this out. A useful way of determining whether this is happening would be a Western blot of Wnt3EGFP-expressing embryos using an antibody against EGFP. This would certainly show whether there was a substantial amount of cleavage, which would be obvious as a band running at the size of EGFP, in addition to a higher band corresponding to the fusion. Moreover, the authors look at the diffusion of injected sec-EGFP. This is an important control, but I think that a better control would be to express the sec-EGFP from the same enhancer that is driving the Wnt3EGFP. It would then be possible to compare exactly the behaviour of the Wnt3 fusion protein with free EGFP.

Another important control would be to show that the Wnt3EGFP distant from the source can induce Wnt signalling as perhaps readout by nuclear β-catenin, or by specific target gene expression.

3) The authors need to provide proof that the heparinase was effective and also that the Lrp5 morpholino was first of all effective, and secondly, specific. They need to show good knockdown of Lrp5, and show that they can rescue the effect with re-expression of Lrp5.

It is also essential to measure the affinity of Lrp5 for Wnt3, as this is crucial to their model.

4) The authors show a big discrepancy in the diffusion coefficients they measure with FCS versus those that they measure with FRAP. This is true of both Wnt3EGFP and also Sec-EGFP, although much more dramatic for Wnt3EGFP. This issue needs resolving with more experiments. For Wnt3EGFP, the authors suggest in the Discussion that this is due to transient binding to receptors and HSPG, but they haven't shown this. This would also affect the FCS measurements, as shown in Table 1 and wouldn't explain the discrepancy for Sec-EGFP. Receptor binding also should influence both the FCS and FRAP measurements. I think that the authors need to explore this in more detail to be certain that the diffusion coefficients that they are measuring with the different approaches are real.

[Editors' note: further revisions were suggested prior to acceptance, as described below.]

Thank you for resubmitting your work entitled "Wnt3 distribution in the zebrafish brain is determined by expression, diffusion and multiple molecular interactions" for further consideration by eLife. Your revised article has been evaluated by Marianne Bronner (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but two of the reviewers have highlighted some remaining issues that should be addressed before acceptance, as outlined below. We leave any further experimental work to your discretion, but if further experiments (e.g. fluorescent ISH to determine source cells) are not possible, please revise the text to indicate some uncertainty in your results. The reviewers have also suggested that it would be useful to discuss your results in the light of the recent paper from the JP Vincent lab. Again, this is not an essential revision, but we wanted to give you the opportunity to see these comments and include this discussion if you wish.

Reviewer #1:

The authors have responded satisfactorily to most of my comments and the manuscript is significantly improved. However, I am still not convinced by the authors' response regarding detecting the source and target regions by colocalization analysis. In particular, even in the clearer images provided of the Wnt3-GFP transcription (supplement to Figure 1), the area appears broader than that of the mApple fluorescence. If for whatever reason, the mApple fluorescence was dimmer than the EGFP signal and more difficult to detect, the colocalizaition analysis could miss the regions where mApple is dimmer. The authors indicate that the lower resolution of the in situ hybridizations makes quantification difficult, which is true, however this is not an inherent limitation as it is possible to perform quantitative fluorescent in situ hybridization. This point is central to the manuscript and I think it is important that the authors address it clearly before publication.

Reviewer #2:

I am happy to see that the manuscript has improved and most of my suggestions have been included in the revised manuscript. I have just a few comments:

I can see that the data for the 7xTCF-mCherry reporter, which shows expression overlapping with the Wnt3GFP signal. However, is there a way to demonstrate that Wnt3GFP regulates the activation of the reporter? I am worried that endogenous Wnt3 or another canonical Wnt regulates the expression of the reporter.

I agree, it would be helpful to exclude that there is free GFP in the Wnt3GFP embryos by a Western blot analysis against GFP (as suggested by reviewer 3).

In a recent publication from the JP Vincent lab it has been suggested that Wg binds to Glypicans (McGough et al., 2020). Would this be a possible mechanism to explain distribution of the fast population of Wnt3GFP? After heparinase treatment, a faster recovery rate was observed with an increase of about a factor 2-3 in Wnt3GFP diffusion coefficient. It is unclear to me how a lipid-modified protein – which is solubilized by glypicans – diffuses faster when the HSPGs are reduced. The authors need to discuss their findings in the light of the most recent published data.

The experiments with Surfen is well done and backs up the point made by the heparinase treatment.

Reviewer #3:

This paper focuses on the mechanism whereby Wnt3 is distributed from the producing cells in the developing zebrafish brain. The authors use a Wnt3EFGP fusion protein under the control of Wnt3 regulatory sequences, and show that it spreads considerably away from the producing cells, as marked by a membrane-bound TmApple fluorescent protein whose production is controlled by the same regulatory elements. They use FCS and FRAP to obtain diffusion coefficients, and demonstrate that HSPGs restrain the mobility of Wnt3. They go on to calculate the binding affinity for the frizzled receptor (Fzd1) and show that Wnt3's ability to bind Fzd1 requires Lrp5. This is a high quality study that demonstrates very nicely long range dispersion of Wnt3, and sheds light on the underlying mechanism.

The revised version of the manuscript is substantially improved and the authors have now addressed all my previous concerns and criticisms.

eLife. 2020 Nov 25;9:e59489. doi: 10.7554/eLife.59489.sa2

Author response


While the reviewers all agreed that the study has potential, they have also identified quite a substantial number of revisions that must be addressed to have confidence in the results and for this study to be of broad interest. Some similar points have come up in all three reviews, which are appended in full below for your information.

Reviewer #1:

1) I am concerned about the comparisons between the source and distribution of Wnt3 using different transgenes with different fluorescent proteins. The data are also presented non-quantitatively so that it is difficult to tell whether, for example, there is mApple fluorescence above background (for source cells) outside of the limited regions described in results. The authors should address: (a) the distribution of Wnt3 mRNA by in situ at 24h (Figure 2—figure supplement 1) appears significantly broader than mApple fluorescence at 24h (b) the source appears to expand considerably from 24 to 48h in mApple fluorescence but there is no corresponding expansion in the Wnt3 mRNA (c) the number of target cells seem to reduce during this time the source is expanding. Data quantifying the distribution of the two fluorescent proteins throughout the region of interest should be shown. It would also be helpful to show in situ data for EGFP so one could compare the source to the target using a single transgene.

To avoid discrepancies in identifying the source and target regions of Wnt3, such as masking of fluorescence expression by background, we quantify the overlap and difference in expression of Wnt3EGFP and PMTmApple by colocalization analysis. Through this, we generate a heat map on the extent colocalization between PMT-mApple and Wnt3EGFP expression in different regions at 24 hpf and 48 hpf. This has been shown in Video 1,2 and the method adopted to quantify colocalization has been discussed in Materials and methods. The colocalized pixels and non-colocalized pixels were subsequently reconstructed to identify the source and distal target regions respectively.

a) The background staining and low resolution 2D images of wnt3 transcript expression makes the interpretation of in situ hybridization images to identify Wnt3 source regions challenging. It is for this reason we use quantitative colocalization analysis of Wnt3EGFP and PMTmApple fluorescence signal to identify the source and distal target regions in this article. We have now provided clear in situ images of wnt3 egfp transcripts expression in Figures 2,3 —figure supplement 3, which corresponds to the identified source regions by colocalization analysis. These results are consistent with previously published results (Clements et al., 2009; Duncan et al., 2016; C. Teh et al., 2015). Additionally, we have also included images of the Wnt reporter line 7xTCF-NLS mCherry, which corresponds to the target regions (Figures 2,3—figure supplement 3).

b) and c) – Yes the source regions seems to be expanding with time and the number of distal target regions seem to be reducing. While optic tectum (OT) was a distal target region at 24 hpf, some dorso-lateral regions of OT act as a source at 48 hpf. We have now included this in our Discussion.

2) The authors should better explain the process of model selection. The text simply says that "Bayesian model selection" is applied without explaining further. The authors should explain how their data justify using a 2-component (fast and slow) model, how much is the fit improved by using 2 components compared to 1 component and by including a triplet state? Given the relatively large number of parameters, how do the authors ensure that they avoid overfitting their data? In this regard, it would be helpful for the authors to subject their controls to the analysis with the same model. For example, if secGFP is analyzed with this model, does it yield Ftrip ~ 0 and Fslow ~ 0?

We explain now the model selection with some more detail in the Materials and methods section of the article. We originally only mentioned the Bayes model selection for Wnt3 as we have previously published these results in an article in Analytical Chemistry (Sun et al., 2015). The Bayes model selection provides a means to determine which model is the most likely given the data and its noise. The results showed that the most likely model (> 80%) is a two-component model including a “triplet”. The “triplet” actually represents the photophysics of EGFP that includes potentially more than one component, i.e. triplet state, protonation-deprotonation equilibria, etc. (Widengren et al., 1999). All data in our experiments are fitted with the two-component model including a triplet, except secEGFP. Bayes model selection indicated a one-component model with triplet as the more likely model (> 80%) for secEGFP. For this protein, we therefore recover only a fast diffusive component and a triplet component due to the photophysics of EGFP mentioned above.

To answer the reviewer’s question on using inappropriate models, if we use the 2 component model with one triplet for secEGFP, then the triplet and first component will provide the same values within the margins of error as the one component with triplet does. But in general the second diffusive component will vary widely often providing nonphysical values for the fraction or diffusion coefficient. The problem is that the quality of fit of the data will seem to increase as the data is essentially overfit and too many parameters are used. Thus, one needs to rely on the ad hoc judgement whether the parameters make sense within the framework of the experiments. To avoid this ad hoc judgement, Bayes model selection provides the basis for preferring one model over the others, optimizing quality of fit and avoiding over fitting by using too many parameters.

3) There isn't sufficient explanation of the biology that the authors believe is behind their measurements. Is the authors' interpretation of the slow fraction that it is bound to the membrane? It is surprising that the slow fraction of Wnt does not differ from that of Lyn which is not secreted? Could this also be Wnt bound to the matrix (e.g. HSPG)? Why does heperanse treatment affect the fast diffusion rate but nothing else? This is supposedly the diffusion of free Wnt. If it is merely clearing more extracellular space, shouldn't the diffusion of secGFP be affected as well? If it is unbinding Wnts from heparin, it would seem that this would be better described by treating bound and unbound Wnts separately.

We thank the reviewer for pointing out the omission. We added now more explanations about our interpretation of the diffusion coefficients in the article. The reviewer is correct and the slow diffusion component represents proteins diffusing in the membrane. Membrane diffusion is not strongly dependent on the size of the protein (Singer and Nicolson, 1972; Weiß et al., 2013) and thus proteins even of quite different size exhibit similar diffusion coefficients. In addition, it is more the location and partitioning of membrane proteins within different lipid/protein domains than their size that determines their diffusion. We have shown this also in two earlier articles (Ng et al., 2016; Sezgin et al., 2017). The latter two articles also demonstrate that Wnt3EGFP is influenced by various interventions changing the lipid content of membranes in cells and in vivo. Therefore, the slow component is likely related to the membrane. Wnts are known to travel in the extracellular spaces by constant binding and unbinding to HSPG (Yan and Lin, 2009). Hence, the change in diffusion coefficient upon HSPG cleavage is only seen for the fast component in the extracellular spaces, and not the slow membrane bound component as shown in Table 1 in the manuscript.

If SecEGFP (33 kDa) and Wnt3EGFP (73 kDa) would diffuse freely one would expect a 30% difference in their diffusion coefficient (D is inversely proportional to the cube root of the mass). As Wnt3EGFP interacts with HSPG it is slowed down in its movement. Thus it diffuses a factor ~2 (=57/28) slower than secEGFP. However, after HSPG disruption, secEGFP and Wnt3EGFP differ by a factor of 60/46=1.3 as expected. The increase for diffusion of Wnt3EGFP is thus a result of it not being retarded anymore by fixed HSPG, and not by a reduction of free space.

Finally, free and bound Wnt3EGFP cannot be treated separately. If Wnt3EGFP would be bound for long times, then we would not see bound Wnt3EGFP diffusing at all and would just see photobleaching of the bound species but no diffusion. Any leftover diffusive species would then be diffusing freely. If however, the interactions are transient, then Wnt3EGFP movement would be slowed down due to constantly binding and unbinding to HSPG. This is what we assume to happen here. However, in this case there is no separate treatment as all Wnt3EGFP would oscillate between free diffusion and binding/unbinding. We clarify these points now in the article.

4) For the measurement of binding affinity, a number is given but the controls are not sufficiently quantitative to give confidence in this number. The best would be to use the same method to calculate a known binding affinity. In the absence of this, is the "binding affinity" computed for the positive control substantially higher than that for Wnt-Frz? In any case, can the authors use this method to spatially map Wnt-Frz interactions in the embryo? This would be more interesting than extracting a binding constant. The authors mention that no binding was detected in the ventral cerebellum or optic tectum but no data is provided.

This is an important point. We therefore now mention a number of references in which we have shown that FCCS can quantitatively determine dissociation constants in cells as in vivo, which are consistent with biochemical experiments as far as available (Shi et al., 2009; Sudhaharan et al., 2009; Wang et al., 2016; Yavas et al., 2016). In these articles, we show that we can determine binding affinities ranging from the low nM to the µM range and that these measurements are consistent with measurements in other labs.

For the positive control, we cannot calculate a binding constant as the two fluorophores are permanently linked. The positive control determines the highest possible cross-correlation amplitude that we can obtain and thus is an important control for us whether we see aggregation or bleaching. Aggregation will change the overall fluorescent properties and can lead to cross-correlations much higher than the positive control. Bleaching would lead to cross-correlations whose amplitude would be inconsistent with the amplitudes of the autocorrelation functions. We mention that we did not detect any binding in the ventral cerebellum and optic tectum as we did not detect any cross-correlations between Wnt3EGFP and Fzd1mApple in these regions. We have now included this data in Figure 6—figure supplement 2 A.

Reviewer #2:

The authors aim to identify and characterise the expression and mobility of Wnt3 ligands within the developing dorsal midbrain of the zebrafish embryo. To do so, the authors use a previously generated transgenic zebrafish line with fluorescently tagged Wnt3GFP and Fz1mApple under the endogenous Wnt3 promoter Tg(-4.0wnt3:) (The et al., 2015). Using these transgenic lines coupled with other fluorescent probes such as secEGFP, LynEGFP and PMTmApple (membrane-tethered EGFP/mApple) under the same regulatory elements, the authors observed that Wnt3GFP is mobilised from the source regions (roof plate of tectum, midbrain-hindbrain boundary, and dorsal cerebellum) to the distal areas around the tectum and cerebellum. The authors then explored the mode of transport by utilising FCS and FRAP technology. FCS analysis suggested that two components of Wnt3GFP were either fast or slow diffusing. Upon further investigation using the heparin sulphate proteoglycan inhibitor, heparinase, it was observed that the fast component of Wnt3GFP was increased. Still, the slow one was unchanged, suggesting that Wnt3GFP is transported extracellularly with the help of HSPGs.

Furthermore, FRAP measurements confirmed this and proved that the recovery of Wnt3GFP was not as a result of cellular protein renewal. Lastly, the authors quantified the interaction between Wnt3GFP and target cell surface receptor Fzd1mApple. This interaction was consistent with in vitro quantification but at a higher dissociation constant, Kd. Finally, the data suggest an importance of co-receptor Lrp5 and identified that Wnt3GFP-Fz1mApple interaction is strongly dependent on Lrp5 expression.

There are two main points of criticism. Firstly, the authors need to demonstrate the bioactivity of Wnt3GFP in the system. This is very important because it is unclear to which extend Wnt3GFP fulfils the function of Wnt3 during development in comparison to the endogenous Wnt3. Furthermore, the authors need to be more explicit in the text that they describe the characteristics of Wnt3GFP and Fzd1mApple – and not the endogenous protein. This needs to be amended at many places in the text/figure legends etc. if appropriate

Thank you for pointing this out. We have shown Wnt3EGFP activity in our earlier publication (Cathleen Teh et al., 2015) and also mention this in our manuscript. We also amended now the article to make clear we describe the FP labelled proteins not endogenous ones.

Secondly, the studies using FCCS to determine the Kd between Wnt3GFP and Fzd1mApple with/without Lrp5 in vivo is a highlight of the paper. I would suggest interfering with Fzd1, Wnt3 and Lrp5 function to demonstrate similar requirements for these three components in midbrain development. Although some publications are suggesting a role in midbrain development for these components, functional validation of the FCCS experiments would significantly strengthen the second core message of the manuscript.

In this study, when the interaction of Wnt3 and Fzd1 was perturbed by knocking-down the expression of co-receptor, we observed defective midbrain and hindbrain development (Figure 6—figure supplement 2). Additionally, we also show that the Wnt3-Fzd1-Lrp5 interaction is also important to modulate the distribution of Wnt3EGFP (Figure 6—figure supplement 3). These results show that interaction of Wnt3-Fzd1-Lrp5 is crucial for zebrafish brain development.

Conclusion: Overall, this paper adopts a robust approach to investigating the in vivo dynamics of Wnt3GFP in the developing zebrafish brain. This paper delivers novel data with little evident criticism of the experimental approach and conclusions drawn.

We thank the reviewer for the comments. We have now included additional discussions on the techniques used and the interpretation of the results. We have also included additional control experiments in our revised manuscript to support our conclusions.

Reviewer #3:

This paper focuses on the mechanism whereby Wnt3 is distributed from the producing cells in the developing zebrafish brain. The authors use a Wnt3EFGP fusion protein under the control of Wnt3 regulatory sequences, and show that it spreads considerably away from the producing cells, as marked by a membrane-bound TmApple fluorescent protein whose production is controlled by the same regulatory elements. They use FCS and FRAP to obtain diffusion coefficients, and demonstrate that HSPGs restrain the mobility of Wnt3. They go on to calculate the binding affinity for the frizzled receptor (Fzd1) and show that Wnt3's ability to bind Fzd1 requires Lrp5.

I think that this is a nice study and for the most part the work is well done. I do think though that in order to interpret the data correctly, considerably more controls are needed. There are also some other missing experiments that would strengthen the findings of the study.

1) The first issue concerns the use of the 4 kb upstream region of Wnt3 to control expression of the Wnt3EGFP and the PMTmApple. The authors say that it is a faithful reporter of Wnt3 expression, yet the wholemount in situs shown show a much wider distribution then the PMTmApple would suggest. This made me wonder whether the expression of the Wnt3EGFP and PMTmApple is actually wider than the authors assume, which would confound the results as it could be that the Wnt3EGFP is not as mobile as they think. To control for this, it is important to perform an EGFP in situ to prove that the source of Wnt3EGFP really is localized.

We have previously shown that in situ expression of egfp transcripts under 4kb wnt3 promoter faithfully reports the wnt3 transcripts expression by imaging cross-sections of different regions of zebrafish brain (C. Teh et al., 2015). This is consistent with the expression of wnt3 transcripts published by other groups (Clements et al., 2009; Duncan et al., 2016). We have also now included the expression of egfp transcripts in Figure 1—figure supplement 1 B,D. Additionally, to validate our distal target regions, we image now a Wnt reporter line, 7xTCF-NLS mCherry, which shows nuclear localized mCherry expression in the target regions we identified. We now include these images in Figure 1—figure supplement 1E,F. However, it is important to note that background signal, overstaining and specificity of riboprobes makes identification of the precise Wnt3 source regions challenging. Moreover, it is difficult to distinguish between the autocrine and paracrine target regions from the Wnt reporter line. Therefore, in this article, we use quantitative co-localization analysis of fluorescence signal from Wnt3EGFP and PMTmApple to identify the source and distal target regions. The sensitivity of fluorescence is also quite high and we therefore think that the quantitative colocalization of fluorescent expressing reporters provide an accurate localization.

Regarding the mobility of Wnt3EGFP, this is exclusively determined by FCS and FRAP. Both methods rely on temporal changes of the fluorescence signal and not on pure spatial distributions. Thus, even if the distribution would suffer from imprecision, the temporal changes would not be influenced by that except of a changing background.

2) The second issue concerns the possibility that free EGFP could be produced by cleavage of the Wnt3EGFP. If this was occurring, then it could contribute to the fast diffusing species measured. The authors must be able to rule this out. A useful way of determining whether this is happening would be a Western blot of Wnt3EGFP-expressing embryos using an antibody against EGFP. This would certainly show whether there was a substantial amount of cleavage, which would be obvious as a band running at the size of EGFP, in addition to a higher band corresponding to the fusion. Moreover, the authors look at the diffusion of injected sec-EGFP. This is an important control, but I think that a better control would be to express the sec-EGFP from the same enhancer that is driving the Wnt3EGFP. It would then be possible to compare exactly the behaviour of the Wnt3 fusion protein with free EGFP.

We clearly see that the diffusion coefficient of Wnt3EGFP, obtained by FCS and FRAP, is much lower than secEGFP in the extracellular spaces as well as in the brain ventricle (Figure 4E, Figure 5 and Figure 5—figure supplement 2). Additionally, we see that Wnt3EGFP interacts with HSPG and with Fzd1mApple while secEGFP does not. These results indicate that we are measuring Wnt3EGFP and not free EGFP cleaved from Wnt3EGFP.

We have now performed FCS and FRAP measurements for secEGFP expressed under the 4 kb Wnt3 promoter and shown that we do not see any differences in the dynamics of secEGFP (Figure 4—figure supplement 1).

Another important control would be to show that the Wnt3EGFP distant from the source can induce Wnt signalling as perhaps readout by nuclear β-catenin, or by specific target gene expression.

This is an important point and we’d like to thank the reviewer for the suggestion. We have now imaged the Wnt reporter line 7xTCF-NLS mCherry and show that the nuclear localized mCherry expression corresponds to the regions we identify as the Wnt3 target regions (Figure 1—figure supplement 1 E,F).

3) The authors need to provide proof that the heparinase was effective and also that the Lrp5 morpholino was first of all effective, and secondly, specific. They need to show good knockdown of Lrp5, and show that they can rescue the effect with re-expression of Lrp5.

To validate our heparinase measurements, we repeated our experiments with surfen, a quinolone based derivative, known to exhibit heparin-neutralizing activity and antagonize heparan sulfate – protein interactions (Naini et al., 2018). We show that both heparinase and surfen treatments provide similar results – increase the Dfast for Wnt3EGFP by a factor ~ 2 (Table 1). Additionally we provide images of Heparinase and surfen treated Wnt3EGFP expressing embryos showing clusters of Wnt3EGFP due to disruption of HSPG (Table 1—source data 1).

Lrp5: The efficacy of the morpholinos used in this study and the phenotypes associated with it have been characterized in (Willems et al., 2015). Upon treatment with lrp5 MO, we show that it results in deformed midbrain and hindbrain and that FCCS is abolished between Wnt3EGFP and Fzd1mApple. As control, we used a lrp5 mismatch morpholino, which did not abolish the Wnt3-Fzd1 interactions and lead to a deformed brain. We include this in Figure 6—figure supplement 2.

It is also essential to measure the affinity of Lrp5 for Wnt3, as this is crucial to their model.

This is a very interesting point and it will be important to measure Lrp5/Wnt3 interactions. We are working on this but this is beyond the scope of this article as this will also require measurements of interactions of Lrp5 with Fzd1 and the determination of the binding sequence.

4) The authors show a big discrepancy in the diffusion coefficients they measure with FCS versus those that they measure with FRAP. This is true of both Wnt3EGFP and also Sec-EGFP, although much more dramatic for Wnt3EGFP. This issue needs resolving with more experiments. For Wnt3EGFP, the authors suggest in the Discussion that this is due to transient binding to receptors and HSPG, but they haven't shown this. This would also affect the FCS measurements, as shown in Table 1 and wouldn't explain the discrepancy for Sec-EGFP. Receptor binding also should influence both the FCS and FRAP measurements. I think that the authors need to explore this in more detail to be certain that the diffusion coefficients that they are measuring with the different approaches are real.

We are sorry that the manuscript has been unclear about this point. FCS measures the local diffusion coefficient (Dlocal) of a molecule in a small observation volume (~ femtoliter range) whereas FRAP measures the global diffusion coefficient (Dglobal) of a molecule across large area (~ tens of micrometres). For Wnt3EGFP we find that Dlocal measured from FCS is 27.6 ± 3.9 µm2/s whereas Dglobal measured from FRAP is 0.5-1 µm2/s. In this article, we investigate the factors that reduces Dglobal 40-100 times when compared with Dlocal. In Table 1 and Figure 5—figure supplement 2, we show that binding of Wnt3EGFP to HSPG slows its diffusion by a factor ~2. In Figure 6—figure supplement 3, we show that interaction of Wnt3 with its receptor and co-receptor slows its diffusion by a factor ~5-6. For secEGFP, we observe that Dglobal (12-15 µm2/s) is 3-5 times slower when compared to its Dlocal (55 – 60 µm2/s) (Figure 4 and Figure 5—figure supplement 3). As secEGFP is only a secreted control that diffuses in the same tissue environment as Wnt3 but does not interact with HSPG or receptors, tortuosity, i.e. the reduction in diffusion due to the presence of cells as obstacles, reduces diffusion of molecules in the interstitial spaces by a factor ~ 3-5. Collectively our results show that long range diffusion of Wnt3EGFP is retarded by a factor 3-5 due to tortuosity, a factor 5-6 due to receptor binding and a factor ∼2 due to HSPG, thus leading to a total reduction of a factor 30-60. These factors alone would be sufficient to explain the discrepancy between FCS and FRAP. We have now explained this more clearly in our article.

[Editors' note: further revisions were suggested prior to acceptance, as described below.]

Reviewer #1:

The authors have responded satisfactorily to most of my comments and the manuscript is significantly improved. However, I am still not convinced by the authors' response regarding detecting the source and target regions by colocalization analysis. In particular, even in the clearer images provided of the Wnt3-GFP transcription (supplement to Figure 1), the area appears broader than that of the mApple fluorescence. If for whatever reason, the mApple fluorescence was dimmer than the EGFP signal and more difficult to detect, the colocalizaition analysis could miss the regions where mApple is dimmer. The authors indicate that the lower resolution of the in situ hybridizations makes quantification difficult, which is true, however this is not an inherent limitation as it is possible to perform quantitative fluorescent in situ hybridization. This point is central to the manuscript and I think it is important that the authors address it clearly before publication.

We are pleased that the reviewer found our revised manuscript improved. The reviewer is correct that if for some reason mApple fluorescence intensity were weak and not detected by confocal imaging, this would underestimate the extent of the Wnt3 source regions. Therefore, in the double transgenic line expressing Wnt3EGFP and PMTmApple, we performed FCS measurements in the regions where Wnt3EGFP but not PMTmApple was detected by confocal imaging (optic tectum and ventral regions). The expression of Wnt3EGFP was used as a guide to ensure FCS measurements were performed on the cell membrane. As FCS is a single molecule sensitive technique, it should detect any low intensity fluctuations present in these regions not captured by confocal imaging. As shown in Figure 2—figure supplement 1 and Figure 3—figure supplement 1, we obtained autocorrelation functions for Wnt3EGFP in these regions but not for PMTmApple, indicating no weak mApple signal were present in these regions. Additionally, we also imaged another reporter line driven by the same 4 kb wnt3 promoter, Tg(4.0wnt3:EGFP), expressing cytosolic EGFP in the domains of endogenous wnt3 (Figure 2—figure supplement 2 and Figure 3—figure supplement 3). The expression pattern of EGFP in Tg(-4.0wnt3:EGFP) closely resembles the expression of PMTmApple in Tg(-4.0wnt3:PMTmApple), further suggesting that mApple intensity was not dimmer than EGFP signal in those regions. However, as the reviewer suggested, performing quantitative fluorescence in situ hybridization will accurately recognize the full range and precise boundaries of Wnt3 source and target regions, but this is beyond the scope of this article. Hence, the full range of source and target regions might be longer than what we had identified. Nevertheless, our results indicates the presence of discrete Wnt3 producing- and receiving-regions in the developing brain of zebrafish embryos. We have now included this in our Discussion section (see paragraph three in Discussion section).

Reviewer #2:

I am happy to see that the manuscript has improved and most of my suggestions have been included in the revised manuscript. I have just a few comments:

We are pleased that the reviewer found our revised manuscript improved.

I can see that the data for the 7xTCF-mCherry reporter, which shows expression overlapping with the Wnt3GFP signal. However, is there a way to demonstrate that Wnt3GFP regulates the activation of the reporter? I am worried that endogenous Wnt3 or another canonical Wnt regulates the expression of the reporter.

The expression of nuclear localized mCherry in 7xTCF-mCherry reporter line is not regulated by Wnt3EGFP but by endogenous Wnt ligands. This reporter line was only used to show that downstream Wnt signaling is activated in the regions distant from the source that we classified as target regions in Figures 2 and 3. We now clarify this in our manuscript (Discussion section, fourth paragraph).

I agree, it would be helpful to exclude that there is free GFP in the Wnt3GFP embryos by a Western blot analysis against GFP (as suggested by reviewer3).

As clarified in our answer to point 2 by reviewer 3 earlier, we see that the diffusion coefficient of Wnt3EGFP, obtained by FCS and FRAP, is much lower than that of secEGFP in the extracellular spaces as well as in the brain ventricle (Figure 4E, Figure 5 and Figure 5—figure supplement 2). Additionally Wnt3EGFP binds to HSPG and interacts with Fzd1mApple while secEGFP does not. These results indicate that we are measuring Wnt3EGFP and not free EGFP cleaved from Wnt3EGFP.

In a recent publication from the JP Vincent lab it has been suggested that Wg binds to Glypicans (McGough et al., 2020). Would this be a possible mechanism to explain distribution of the fast population of Wnt3GFP? After heparinase treatment, a faster recovery rate was observed with an increase of about a factor 2-3 in Wnt3GFP diffusion coefficient. It is unclear to me how a lipid-modified protein – which is solubilized by glypicans – diffuses faster when the HSPGs are reduced. The authors need to discuss their findings in the light of the most recent published data.

The increase in the diffusion coefficient of the fast component by a factor ~ 2 after disrupting HSPG suggests that Wnt3 spreads by extracellular diffusion and that binding of Wnt3 to HSPG regulates its diffusion. As Wnts are known to travel in the extracellular spaces by transient binding and unbinding to HSPG (Yan and Lin, 2009), the increase in diffusion coefficient upon HSPG cleavage is only seen for the fast component which is diffusing in the extracellular spaces. Our results are in line with the recent findings of JP Vincent lab (McGough et al., 2020) who also reported that Wnt ligands travel long distance by interacting with glypicans, a major family of HSPG, through its lipid moiety. This is indeed a possible mechanism that explains the spreading of the fast component of Wnt3EGFP. Collectively, these results imply that the extracellular diffusion of Wnt ligands are regulated by HSPG. We have now included this in the Discussion section.

References

Singer, S. J., & Nicolson, G. L. (1972). The fluid mosaic model of the structure of cell membranes. Science, 175(4023), 720–731.Weiß, K., Neef, A., Van, Q., Kramer, S., Gregor, I., & Enderlein, J. (2013). Quantifying the diffusion of membrane proteins and peptides in black lipid membranes with 2-focus fluorescence correlation spectroscopy. Biophysical Journal, 105(2), 455–462.Widengren, J., Mets, Ü., & Rigler, R. (1999). Photodynamic properties of green fluorescent proteins investigated by fluorescence correlation spectroscopy. Chemical Physics, 250(2), 171–186.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Figure 4—source data 1. Diffusion coefficients of Wnt3EGFP and secEGFP at cell borders and in the brain ventricle.
    Table 1—source data 1. Tg(−4.0wnt3:Wnt3EGFP) embryos treated by heparinase and surfen.

    (A) The expression of Wnt3EGFP after heparinase treatment. (B) Distribution of Dextran-TRITC coinjected with heparinase in the BV of Tg(−4.0wnt3:Wnt3EGFP) embryo. (C) Expression of Wnt3EGFP after surfen treatment. BV, brain ventricle; Ce, cerebellum. Images orientation: anterior to the left. Scale bar 50 μm.

    Table 1—source data 2. Individual fluorescence correlation spectroscopy measurements of Wnt3EGFP, LynEGFP, and secEGFP embryos before and after heparan sulfate proteoglycan disruption.
    Figure 5—source data 1. Individual fluorescence recovery after photobleaching measurements of Wnt3EGFP and secEGFP embryos.
    Figure 6—source data 1. Apparent dissociation constant (Kd) calculation for Wnt3-Fzd1 interaction and fluorescence recovery after photobleaching recovery rates after lrp5 knockdown.
    Transparent reporting form

    Data Availability Statement

    All data analyzed during this study are included in the manuscript as source files. Source data files have been provided for Figures 4, 5, 6 and Table 1. Videos 1 and 2 represent the raw file used to construct Figures 2-3 and Videos 3-4, respectively.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES